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3ABSTRACT
The capability of Clostridium botulinum to survive food processing and grow 
in foods is a substantial hazard to human health. Clostridium botulinum can 
thrive under stress conditions and the wide genetic variation among C. botulinum 
strains reflects differences in their growth properties. However, the strain vari-
ation in growth, molecular mechanisms, and genetic markers behind the stress 
tolerance of C. botulinum are poorly understood. This study focused on the 
variation in growth of Group II C. botulinum strains at temperatures out of the 
optimal range and characterized the role of the genes that are involved in the 
stress response of Group I ATCC 3502 and Group II Beluga strains.
At extreme temperatures, Group II C. botulinum strains showed significant 
variation. Some strains showed better growth at 37 °C than their generally 
accepted optimum growth temperature of 30 °C. Although not absolute, the 
minimum growth temperatures of 24 Group II strains in our experimental set-
ting were higher than expected. The AFLP typing indicated a weak association 
between genetic background and growth at extreme temperatures. In addition, 
clustering analysis showed that the type B and F strains are closely related, since 
they were clustered together, and the type E strains formed a separate cluster. 
Our data indicated that Group II C. botulinum strains show considerable dif-
ferences in their growth properties, and this should be taken into account in 
designing safety measures against this foodborne pathogen.
The study implied that csp genes play important roles in NaCl, pH, and 
ethanol stress and motility of C. botulinum ATCC 3502. The growth of the 
cspB mutant was impaired in relation to the wild-type strain under all stress 
conditions tested, suggesting a universal role in stress response. Additionally, 
functional cspC was required for efficient growth during NaCl, pH, and ethanol 
stress. The cspA did not take part in NaCl, pH, and ethanol stress responses, and 
inactivation of this gene enhanced growth, which suggested a possible growth 
repressor role. In addition, cspB was not involved in motility, but cspA and 
cspC were crucial for flagellation and motility.
The two-component system CBO2306/CBO2307 of Group I C. botulinum 
ATCC 3502 and CLO3403/CLO3404 of the Group II Beluga strain were in-
duced up to 4.4- and 3.4-fold, respectively, after cold shock, but not at optimum 
growth temperatures. This indicated that both systems were involved in rapid 
response to cold shock. This argument was further confirmed by inactivation 
of the CBO2306/CBO2307 or CLO3403/CLO3404 genes, which resulted in 
impaired ability of the mutant strains to grow at low temperatures compared 
4with the wild-type strains. In addition, the histidine kinase encoding clo3403 
was required for motility. 
The cbo2802 that encodes the DEAD-box RNA helicase in C. botulinum 
ATCC 3502 was cold-inducible. The RT-qPCR analysis showed a 7.6-fold rap-
id increase in the relative expression of cbo2802 after cold shock. The signif-
icance of cbo2802 in the growth at suboptimal temperature of C. botulinum 
ATCC 3502 was further characterized by disruption of this gene. The mutants 
without functional cbo2802 showed impaired growth and restricted motility at 
suboptimal temperature. 
This study concluded that strains of Group II C. botulinum pose considerable 
variation in growth properties, which may be of critical importance in predic-
tive modeling of growth in foods. The major cold-shock protein-encoding gene 
cspB seems to play a universal role in stress response and cspC a role in NaCl, 
pH, ethanol stress, and motility. The cspA gene is not involved in the stress 
response of C. botulinum ATCC 3502, but is important for flagella formation. 
The CBO2306/CBO2307 in Group I C. botulinum ATCC 3502 and CLO3403/
CLO3404 in the Group II Beluga strain are part of the cold stress response 
machinery. Moreover, clo3403 is required for motility. We report for the first 
time in C. botulinum that DEAD-box RNA helicase is crucial for growth at sub-
optimal temperature and motility.
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A.D. anno Domini
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BIG-IV Human-derived botulism immune globulin intravenous
BoNT  Botulinum neurotoxin
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csp Cold-shock protein-encoding gene
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HC Heavy chain of botulinum neurotoxin
HK  Histidine kinase of two-component signal transduction system
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NTNH Nontoxic nonhemagglutinin component of botulinum neurotoxin
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ODU Optical density unit
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PCR  Polymerase chain reaction
POP-4 Performance Optimized Polymer 4
REPFED Refrigerated processed food of extended durability
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RNA Ribonucleic acid
RNP Ribonucleoprotein
RR  Response regulator of two-component signal transduction system
rRNA Ribosomal ribonucleic acid
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RT-qPCR  Quantitative reverse-transcription real-time polymerase chain 
 reaction
SNAP25 Synaptosomal-SNARE associated protein of molecular mass 
 25 kDa
SNARE Soluble N-ethylmaleimide-sensitive factor attachment protein 
 receptor 
TCS  Two-component signal transduction system
TPGY  Tryptone -peptone-glucose-yeast extract
tRNA Transfer ribonucleic acid
UV  Ultraviolet 
VAMP Vesicle-associated membrane protein
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1  INTRODUCTION
Food preparation and storage practices have been applied by humankind for 
thousands of years to sustain long-term food supplies. When such practices are 
inadequate to prevent pathogenic organisms from contaminating and multiply-
ing in foods, and hence threatening life, food safety measures have been used. 
For example, Emperor Leo VI (886-911 Anno Domini) of the Eastern Roman 
Empire set a prohibitory rule concerning the production and consumption of 
blood sausage to prevent food poisonings. The prohibition included a series 
of hard punishments. As stated, “A person found to have prepared blood as 
food, whether he sells it or buys it, shall have all his property confiscated, and, 
after having been severely scourged and disgracefully shaved, shall be exiled for 
life” (Tony, 2000; Erbguth, 2004). The aforementioned food poisoning, later 
thought to be botulism, was caused by a rod-shaped, anaerobic spore-former, 
Clostridium botulinum which was identified in the 19th century. 
The first clear reports known to describe botulism were published by a Ger-
man poet and medical officer, Justinus Kerner (1786–1862) (Erbguth & Nau-
mann, 1999). He was also the first to anticipate the therapeutic implications 
of botulinum neurotoxin (BoNT). He called the BoNT ’sausage toxin’ or ’fatty 
acid’ (Kerner, 1822; Erbguth & Naumann, 1999). Based on his observations, he 
concluded that BoNT, when applied in minimal doses, would stop hyperactive 
nervous functions. In his 1822 monograph, he discussed the therapeutic use of 
the toxic fatty acid to treat hypersecretion of body fluids and sweat, ulcers, skin 
deformations due to burning, delusions, rabies, and plague (Erbguth & Nau-
mann, 1999). More than 70 years after Kerner’s monograph, on December 14 
1895 in a small town called Ellezelles, three young men of a music band aged, 
between 15 and 21, died within a week after attending a funeral dinner. They 
had all eaten contaminated pickled home-smoked ham (Devriese, 1999). Lat-
er, the causative agent was identified and isolated by a Belgian bacteriologist, 
Emile Pierre-Marie Van Ermengem from the contaminated ham and the victims 
(van Ermengem, 1897; Devriese, 1999; Erbguth, 2008). He called the organ-
ism Bacillus botulinus, botulus meaning sausage in Latin (later renamed as C. 
botulinum), not due to its sausage like shape but to its pathological association 
with sausage poisonings, as Kerner described (Kerner, 1822; van Ermengem, 
1897; Torrens, 1998). 
In the following decades, although scholars had difficulties in isolating C. 
botulinum from the environment, botulism outbreaks continued (Burke, 1919b). 
New toxin types were found and foodstuffs other than meat were associated 
14
with botulism (Burke, 1919b; Bengtson, 1922; Hazen, 1937; Møller & Schei-
bel, 1960). Studies of the physiology of various C. botulinum toxin types have 
revealed distinct metabolisms of these strains; thus they pose different safety 
hazards in foods (Lindström et al., 2006b). Intra- and/or inter strain variation 
among Group I and II and capability of C. botulinum for growing at refrigeration 
temperatures (Graham et al., 1997) and for tolerating various environmental 
stresses is a severe risk for the modern food industry (Peck, 1997, 2006; Lind-
ström et al., 2006b; Peck et al., 2008). The availability of genome sequences 
and genetic manipulation tools has enhanced the understanding of stress re-
sponse mechanisms in C. botulinum. However, reports are scarce on stress 
response machinery. It is essential to study the mechanisms that are involved 
in the stress response of C. botulinum to counter the safety hazards caused by 
this notorious pathogenic organism.
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2  REVIEW OF THE LITERATURE
2.1 Clostridium botulinum and botulism
2.1.1 Classification of C. botulinum
Clostridium botulinum is a Gram-positive, rigorously anaerobic rod that forms 
heat-resistant subterminal spores and, most importantly, during vegetative 
growth produces BoNT (Cato et al., 1986). Clostridium botulinum is defined 
as a low-G+C deoxyribonucleic acid (DNA)-containing organism (26–28%) 
(Johnson & Francis, 1975; Shukla & Sharma, 2005; Sebaihia et al., 2007; Peck, 
2009). Due to diverse genetic, metabolic, and physiologic features of C. bot-
ulinum strains, the species is divided into four groups, I through IV (Table 1) 
(Johnson & Francis, 1975; Smith & Sugiyama, 1988; Hatheway, 1993; Collins 
& East, 1998; Keto-Timonen et al., 2006).
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Classification of C. botulinum as a species stands on the common property of 
these strains of producing BoNT, and this remains the determinant for their 
name. However, the discovery of BoNT-producing Clostridium butyricum and 
Clostridium baratii strains further complicated this classification (Suen et al., 
1988). In fact, C. botulinum is heterogeneous enough to enable characterization 
of these strains as different species (Hutson et al., 1993; Collins & East, 1998; 
Hill et al., 2007; Peck et al., 2011). Based on their 16S rrn sequences, the Group 
I strains are more closely related to nontoxigenic C. sporogenes than to the 
Group II strains, which are clustered together with C. acetobutylicum and C. 
beijerinckii (Hatheway, 1993; Hill et al., 2007). Similar closer relationships were 
observed for Group III and Group IV strains to C. novyi and C. subterminale, 
respectively, than to Group I or II C. botulinum (Hielm et al., 1999; Hill et al., 
2007). Moreover, the novel species name C. argentinense was urged for Group 
IV strains (Suen et al., 1988). 
Strains belonging to Groups I and II are known to cause botulism in humans 
and Group III in other animals, and yet no reports are available on botulism 
due to Group IV strains. Although toxins produced by distinct C. botulinum 
strains, these different toxin types show the same pharmacologic effect on their 
victims, but their serologic traits may vary (Collins & East, 1998; Popoff & 
Bouvet, 2013; Barash & Arnon, 2014). To date, seven serologically different 
BoNT types have been identified and designated as A through G (Burke, 1919a; 
Bengtson, 1922; Meyer & Gunnison, 1929; Gunnison et al., 1936; Møller & 
Scheibel, 1960; Gimenez & Ciccarelli, 1970). A recent report suggests a new 
toxin type designated as type H, in which protection against this strain could 
not be achieved by heptavalent botulinum antitoxin A–G (Barash & Arnon, 
2014). On the other hand, decisive and definitive findings over the new toxin 
type are pending (Johnson, 2014). 
Group I strains produce either single-toxin type A, B, and F, or dual toxins 
Ab, Af, Ba, Bf, and Bh, in which the small letter represents a lesser amount of 
toxin produced relative to the toxin type indicated by a capital letter (Dover et 
al., 2013; Hill & Smith, 2013; Barash & Arnon, 2014). There are strains that can 
produce equal amounts of type A and B toxins, hence are designated as AB type, 
shown with both capital letters (Barash & Arnon, 2014). In addition, Group I 
strains may also carry both A and B toxin genes but produce only A toxin, marked 
as A(B), noting the ’silent’ B toxin gene in brackets (Franciosa et al., 1994). In 
terms of toxin production, Group II strains represent less variety and generate 
only one of the B, E, or F BoNT serotypes (Peck, 2009). Even though traces 
of B and E toxin gene sequences have been found in the serotype F-producing 
Group II strain (Carter et al., 2013), hitherto no dual toxin-producing Group 
18
II strains have been reported. Group III strains produce toxin types C or D or 
combinations of the two as mosaic toxins and Group IV produces toxin type G 
(Hill & Smith, 2013). Studies on the genetic background of C. botulinum have 
also demonstrated wide intragroup diversity (Hielm et al., 1998b, 1999; Hyytiä 
et al., 1999b; Keto-Timonen et al., 2005; Nevas et al., 2005a; Hill et al., 2007; 
MacDonald et al., 2011; Stringer et al., 2013), indicating that C. botulinum is a 
considerably diverse species. 
2.1.2 Physiology of C. botulinum
The wide genetic diversity among C. botulinum strains is reflected in their phys-
iological properties, hence strains of different groups exhibit diverse phenotypic 
characteristics (Table 1) (Lynt et al., 1982; Cato et al., 1986; Hatheway, 1993; 
Lindström & Korkeala, 2006). Group I consists of mesophilic organisms with 
optimum growth temperatures of 37 °C or higher and show high proteolytic 
activity (Hatheway, 1993; Hinderink et al., 2009). They form spores of high 
heat resistance (Stumbo et al., 1975). Although minimum and maximum growth 
temperature limits vary among strains, the generally accepted range is 10–48 °C 
(Lynt et al., 1982; Hinderink et al., 2009). Their growth is repressed by a water 
activity (aw) value of 0.94 that corresponds to 10% NaCl w/v in brine (Cliver et 
al., 2011), and growth is suppressed at pH 4.6 (Smelt et al., 1982). 
Unlike Group I, strains of Group II C. botulinum are considered to be psy-
chrotrophic and can grow at temperatures as low as 3 °C (Schmidt et al., 1961; 
Eklund et al., 1967a, 1967b; Graham et al., 1997). Their optimum growth tem-
perature is between 26 and 30 °C (Smith & Sugiyama, 1988; Hatheway, 1993) 
and growth can occur at up to 45 °C (Johnson, 2000). Group II C. botulinum 
represents a more diverse genetic background than Group I strains (Hill et 
al., 2009; Stringer et al., 2013), and it is not well known how the large genetic 
background of Group II strains is reflected in growth characteristics at extreme 
temperatures. 
 In contrast to Group I, Group II strains cannot utilize amino acids as their sole 
energy source, therefore the terminology nonproteolytic C. botulinum is adopted 
for these organisms. On the other hand, they are highly saccharolytic and ferment 
a number of sugars (Cato et al., 1986). The growth-restraining water-phase NaCl 
concentration and aw for Group II strains are 5% and 0.97, respectively (Smith 
& Sugiyama, 1988). Growth is not reported below pH 5.0 (Segner et al., 1966). 
They produce less heat-resistant spores than Group I strains.
Group III C. botulinum strains are composed of mesophilic organisms with 
an optimum growth temperature of 40 °C (Smith & Sugiyama, 1988). Growth 
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is restricted at temperatures below 15 °C, and they are more susceptible to low 
pH and NaCl concentrations (growth is inhibited by pH of 5.1–5.6 and a brine 
content of 2.5% w/v) than the strains belonging to Groups I and II (Segner et 
al., 1971). Group III strains are poorly proteolytic, or some strains may lack this 
activity, and they form spores of intermediate heat resistance compared with 
those of Groups I and II (Hatheway, 1993; Peck, 2009). Group IV strains are 
proteolytic with an optimum growth temperature of 37 °C and, unlike Group 
I–III strains, they lack lipase activity (Hatheway, 1993; Minton, 1995). 
2.1.3 Botulinum neurotoxin 
Botulinum neurotoxin and mode of action 
BoNT is the most potent natural toxin known, and its estimated lethal dose 
to humans is less than 100 ng (Arnon et al., 2001; Sesardic et al., 2004; Peck, 
2009; Miethe et al., 2014). This unusual potency has aroused concerns on de-
ployment of BoNT as a biological weapon (Arnon et al., 2001; Sesardic et al., 
2004). Despite their infamous connotation, the pioneering works by Alan Scott 
(Scott et al., 1973; Scott, 1981) led to the therapeutic and cosmetic uses of BoNT 
(Clark & Berris, 1989; Jankovic & Brin, 1991).
In addition to BoNT serotypes, variants within serotypes have been identified 
and noted as subtypes with an Arabic number (Hill et al., 2007; MacDonald et 
al., 2011; Hill & Smith, 2013). However, the definition of these subtypes is not 
clear. Some studies have defined a subtype for differences in its amino-acid 
sequence of more than 2.5% in comparison to the sequence of a BoNT gene in 
a strain that produces the same toxin serotype (Smith et al., 2005; Carter et 
al., 2009; Hill & Smith, 2013), others by clade analysis in which a new subtype 
clustered separately from existing subtypes (Chen et al., 2007; Hill et al., 2007; 
Raphael et al., 2010). In addition, an effective way of determining a subtype is 
neutralization of BoNT with monoclonal and polyclonal antibodies (Kalb et al., 
2009; Mazuet et al., 2010; Tepp et al., 2012). To date, five variants of serotype 
A (A1–A5) (Willems et al., 1993; Carter et al., 2009), seven variants of serotype 
B (B1–B7) (Hutson et al., 1994; Kalb et al., 2012a), nine variants of serotype E 
(E1–E9) (Poulet et al., 1992; Raphael et al., 2012), and seven variants of serotype 
F (F1–F7) (Thompson et al., 1993; Raphael et al., 2010) have been discovered. 
The clinical importance of these variants is in harboring differences in their ca-
pacity to be neutralized by type-specific antibodies (Smith et al., 2005; Arndt et 
al., 2006). Detection and characterization of new serotypes and unique immu-
nologic and enzymatic activities of the variants indicates that new toxin types 
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and variants are yet to be discovered (Carter et al., 2013; Dover et al., 2014). 
BoNT is a single-chain polypeptide with a molecular mass of 150 kDa (Saka-
guchi, 1982; Melling et al., 1988; Popoff & Bouvet, 2013). The single-chain 
toxin molecule subsequently undergoes proteolytic activation, either by its own 
bacterial protease (proteolytic Group I strains) or host-provided enzyme (non-
proteolytic Group II strains), resulting in significant increases in its potency 
(Simpson & Dasgupta, 1983). The process is called ’nicking’ and generates a 
cleaved dichain toxin molecule consisting of a 50-kDa light chain (LC) and 100-
kDa heavy chain (HC) that are connected by a single disulfide bond (Yokosawa 
et al., 1986; DasGupta, 1989). The LC is a zinc-dependent metalloproteinase 
and the HC consists of two 50-kDa functional domains (Schiavo et al., 1992; 
Turton et al., 2002). The C-terminal domain of HC is involved in binding of 
the toxin molecule with high affinity to the receptors located on the neuron 
cell surface (Montecucco, 1986). The binding is followed by irreversible recep-
tor-mediated internalization of the BoNT into the cell cytoplasm via endocytosis 
(Humeau et al., 2000; Simpson, 2004). Inside the endosome, acidification of 
the endosome lumen occurs and, via the N-terminal of the HC, BoNT undergoes 
a conformational change. The disulfide bond between the LC and HC breaks 
apart and translocation of the LC from the endosome to the cytoplasm occurs 
(Schiavo et al., 2000; Elias et al., 2011). The LC in the cytoplasm establishes its 
protease activity by cleavage of specific proteins that are responsible for docking 
and adhesion of the neurotransmitter-containing vesicle at the nerve terminal 
(Schiavo et al., 2000; Simpson, 2004). This leads to blocking of the release of 
the neurotransmitter into the neuromuscular junction and results in flaccid 
paralysis. Each of the three 50-kDa domains of the 150-kDa BoNT performs its 
individual function without the presence of the other two (DasGupta, 2006). 
The proteins essential for the signal release events are called soluble N-eth-
ylmaleimide-sensitive factor attachment protein receptors (SNAREs) and are 
cleaved by BoNT with extreme specificity. The BoNT/A, E, and C cleave a syn-
aptosomal-associated protein of molecular mass 25-kDa (SNAP25) at positions 
glutamine197 – arginine198, arginine180 – isoleucine181, and arginine198 – alanine199, 
respectively. In addition to SNAP25, BoNT/C cleaves syntaxin at position ly-
sine253 – alanine254, while BoNT/B, D, F, and G cleave vesicle-associated mem-
brane protein (VAMP) at positions glutamine76 – phenylalanine77, lysine59 – 
leucine60, glutamine58 – lysine59, and alanine81 – alanine82, respectively (Jones 
et al., 2008, 2009). Interestingly, BoNT/F5 cleaves VAMP at a site different 
from that of the other BoNT/F variants (leucine54 – glutamic acid55) (Kalb et al., 
2012b). The cleavage site of BoNT/H was predicted to be the same for BoNT/
F5, due to 80% amino-acid identity in the LC between BoNT/F5 and BoNT/H 
(Dover et al., 2014). However, this remains to be experimentally characterized.
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Neurotoxin gene cluster and auxiliary proteins
Clostridium botulinum secretes the neurotoxin during its vegetative growth, with 
peak production occurring at the late logarithmic growth phase (Bradshaw et al., 
2004; Lövenklev et al., 2004; Chen et al., 2007). The BoNT is not synthesized 
as a homogeneous toxin molecule, but is produced together with nontoxigenic 
auxiliary components comprising a progenitor toxin (Kitamura et al., 1968; 
Sugii & Sakaguchi, 1975; Minton, 1995; Oguma et al., 1999). The progenitor 
toxin complex is encoded by several genes. These genes are in close proximity 
(toxin gene cluster) and appear to be a mobile genetic element that can insert 
itself at specific genetic locations in plasmids, bacteriophages, and the clostridial 
chromosome (Table 1) (Hill et al., 2009; Carter et al., 2013; Zhang et al., 2013b). 
The BoNT gene cluster generally exists as two main formations (Brügge-
mann & Gottschalk, 2009). The cluster that consists of hemagglutinin (HA) 
genes (ha33, ha17, and ha70), nontoxic-non-HA (NTNH) gene (ntnh), and the 
BoNT gene (bont), is called the ha+/orfx- cluster. The ntnh and bont constitute 
a single transcriptional unit, while the HA-encoding genes are located on the 
upstream side of ntnh-bont and are transcribed in the opposite direction (Hill 
et al., 2009; Peck, 2009). Between the two independent transcriptional units, 
another gene that encodes an alternative sigma factor (botR) is present and its 
product, BotR, is involved in regulation of bont (Dupuy & Matamouros, 2006). 
In the other arrangement, the HA-encoding genes are absent and the toxin clus-
ter accommodates three open reading frames (ORFs) (orfx1, orfx2, and orfx3) 
and a gene designated as p47 of unknown function (Chen et al., 2007; Hill et 
al., 2009; Peck et al., 2011). 
The role of the auxiliary proteins is not well understood. Epithelial cell line 
based assays indicate that HA proteins are pathogenic factors that disrupt the 
paracellular barrier of the intestinal epithelium, hence promote the distribu-
tion of BoNT into the extracellular space (Matsumura et al., 2008; Fujinaga et 
al., 2009; Jin et al., 2009). Inhalation absorption of BoNT in vivo showed that 
the rate of absorption, toxicity, or circulating titers of BoNT did not rely on the 
presence of HA components (Al-Saleem et al., 2012). Moreover, serotypes E 
and F are produced free of HA proteins and yet cause oral toxicities (Dolman 
& Iida, 1963; Lindström et al., 2004; Gupta et al., 2005; King et al., 2009). The 
involvement of HA in absorption of BoNT and the mechanisms behind it are 
unclear. On the other hand, the function of the NTNH component appears to 
be a protective binding of BoNT from gastric degradation (Gu et al., 2012). The 
role of auxiliary HA and NTNH is one of the puzzles of the progenitor toxin 
molecule that are yet to be fully resolved. The information available indicates 
that the oral toxicity of the progenitor toxin is greater than that of the toxin 
molecule without auxiliary components (Bonventre, 1979). In addition, these 
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auxiliary proteins are inessential for the paralytic effect of BoNT (DasGupta & 
Boroff, 1968; Beers & Reich, 1969). Therefore, that a protective function of HA 
and NTNH occurs over the BoNT against gastric degradation, thus allowing 
more toxin available for absorption from the gut, is a generally accepted con-
cept (Simpson, 2013). 
The association between the OrfX and P47 proteins that occurs with no 
designated function and BoNT is not clear. The OrfX2, OrfX3, and P47, but 
not OrfX1, are expressed in serotype A2 culture (Lin et al., 2010). Using mass 
spectrometry, Hines and coworkers (2005) could detect OrfX1 in serotype E, 
but not in F, whereas OrfX2 and P47 could not be detected in either serotype. 
It has been suggested that OrfX botulinum complexes are possibly unstable and 
can easily dissociate (Popoff & Connan, 2014). 
2.1.4 Botulism
Botulism is an acute neuroparalytic disease and may occur from intoxication 
with BoNT, such as foodborne, inhalation, and iatrogenic botulism, or infec-
tion in the forms of infant, wound, and adult intestinal botulism (Lindström 
& Korkeala, 2006). In all forms, botulism results from the BoNT reaching the 
peripheral nerve endings via the bloodstream. Due to the relatively high blood 
flow and dense innervation of the cranial muscles, the clinical manifestations 
of botulism initially arise from the muscles of the head, face, mouth, and throat 
(Arnon, 1997). Double or blurred vision, difficulty in speaking and swallowing, 
dry mouth, and facial paralysis are typical symptoms of botulism. As the disease 
develops, symmetrical cranial flaccid paralysis descends through the limbs. The 
recovery of muscles begins as the affected axons regenerate synaptic activity 
by sprouting new endplates (Meunier et al., 2002). However, in severe cases 
arrest of the respiratory muscles may lead to death. 
Foodborne botulism
Foodborne is the earliest described form of botulism and is also called ’classical 
botulism’. It occurs due to ingestion of food contaminated with BoNT. Spores 
can germinate and outgrow in foods, particularly when spores of C. botulinum 
survive food processing and when conditions are suitable for growth (Table 1). 
Subsequently, during vegetative growth and cell lysis, BoNT is released into the 
food. Depending on the amount of BoNT consumed, the time of symptom onset 
may vary (12–72 h) (Lindström & Korkeala, 2006). The metabolic by-prod-
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ucts of growth of C. botulinum may trigger gastrointestinal symptoms, such as 
nausea, vomiting, and diarrhea (Arnon, 1997). Constipation may follow as the 
flaccid paralysis becomes apparent. The treatment includes intensive care of 
the patient and intravenous administration of antitoxin. The antitoxin admin-
istration should be done as quickly as possible to eliminate circulating BoNT. 
However, it should be noted that antitoxin treatment may cause side effects, 
due to the animal origin of the antitoxin (Black & Gunn, 1980; Hibbs et al., 
1996). The foods often associated with foodborne botulism are home-prepared 
canned vegetables and fermented marine products. In addition, mildly treated 
foods with modified atmosphere packaging and vacuum-packaged fish products 
are also reported to be a source of botulism (Korkeala et al., 1998; Sobel et al., 
2004; Lindström et al., 2006a). 
Botulism is a rare disease and symptoms may not be conclusive, hence rapid 
diagnosis is challenging (Forss et al., 2012). There are methods helpful in iden-
tifying the source and support diagnosis by isolating C. botulinum or detecting 
BoNT from the patient or suspected foodstuffs. Although the standard test for 
diagnosis of botulism is the mouse neutralization assay, which requires suitable 
facilities, trained personnel, and time (Lindström & Korkeala, 2006), there has 
been significant development in immunologic detection methods to reduce or 
replace living animals (Sesardic et al., 1996; Jones et al., 2009; Adler et al., 
2010; Sesardic & Das, 2007; Keto-Timonen et al., 2014). 
Infant botulism
Infant botulism results from a sequence of events that involves ingestion and 
germination of spores of C. botulinum or BoNT-producing clostridia, coloniza-
tion and growth of vegetative cells, and finally release and absorption of BoNT 
in the infant colon (Arnon, 1998). A case was defined as laboratory- confirmed 
botulism that occurred in an infant less than 1 year of age and was not caused 
by ingestion of food containing BoNT (Koepke et al., 2008). Foodborne bot-
ulism has rarely been reported in infants (Armada et al., 2003; Berkes et al., 
2007; Lonati et al., 2011). However, infant botulism is the most common form 
of botulism in the United States (Arnon, 1997). The principle route for infant 
botulism has been proposed to be the spores in honey and dust (Arnon et al., 
1979; Nevas et al., 2002, 2005b; Grant et al., 2009; Derman et al., 2013), and 
the infectious dose was estimated to be between 10 and 100 spores (Arnon, 
1998). The susceptibility to colonization by BoNT-producing clostridia of infants 
less than 1 year of age results from lack of competitive gut microbiota (Fenicia 
& Anniballi, 2009).
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 Symptoms of infant botulism include constipation, or no defecation for several 
days, poor feeding, weak cry, drooling, generalized weakness, hypotonia, and in 
all cases bulbar palsies (Arnon, 1997). The diagnosis is made by detecting BoNT 
in the serum or isolating BoNT-producing organisms from the ill infant’s stool. 
EMG (electromyography) may aid in diagnosis by finding a typical BSAP (brief, 
small, abundant motor unit action potential) pattern in the clinically affected 
muscles (Engel, 1975; Francisco & Arnon, 2007). Nevertheless, the type of toxin 
that is responsible for the illness should be determined by the mouse neutraliza-
tion assay for the case to be registered as infant botulism (Koepke et al., 2008). 
Until recently, the treatment of infant botulism has been mainly supportive 
care, and antibiotic treatment should be used to treat secondary infections, be-
cause antibiotics may lyse vegetative C. botulinum cells in the infant gut, hence 
freeing BoNT for absorption (Arnon, 1997). Since 2003, a specific treatment for 
infant botulism caused by type A and B is available as human-derived botulism 
immune globulin intravenous (BIG-IV) (Arnon et al., 2006). 
The fecal excretion of BoNT and C. botulinum in affected infants may con-
tinue for an extremely long period of time and especially after full clinical re-
covery and discharge from the hospital (Derman et al., 2013). Therefore, C. 
botulinum may pose a possible health risk for the parents and others in close 
contact with the ill infant. Although cross-contamination cases have not been 
reported (Koepke et al., 2008), soiled diapers should be autoclaved and con-
scientious handwashing is advisable when managing infant botulism patients. 
Wound botulism
Wound botulism results from contamination of deep lacerations with C. bot-
ulinum spores from the environment. Contaminated lesions such as necrosis 
or abscesses may provide anaerobic conditions, thus allowing spores of C. bot-
ulinum to germinate and subsequently produce BoNT in a wound. Symptoms 
of wound botulism are similar to those seen in foodborne botulism, except for 
the absence of gastrointestinal symptoms (Arnon, 1997). Since the first de-
scription of wound botulism in 1943, this rare infectious form of botulism has 
occurred mostly due to traumatic injuries (Swedberg et al., 1987; Cherington, 
1998). However, in the early 1990s the epidemiology of wound botulism changed 
and the number of cases has increased (MacDonald et al., 1986; Werner et al., 
2000). The increased number of cases has been associated with injecting drug 
users, due to impure heroin or contaminated injection equipment (Passaro et 
al., 1998; Werner et al., 2000; Brett et al., 2004; Akbulut et al., 2005; Sieradzan, 
2005). Treatment of wound botulism includes antitoxin administration, surgical 
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cleaning of suspected wounds, and suitable antibiotic treatment (Sieradzan, 
2005; Sobel, 2005).
Other types of botulism
Botulism may occur in adults as an infectious form. These patients reflect no 
history of consumption of BoNT-containing food, wounds, or drug injection. 
However, a number of intestinal abnormalities, e.g. achlorhydria, Crohn’s disease, 
or alteration of the intestinal microbial population with antibiotics, due to surgery 
or inflammation is present, hence allowing intestinal colonization of BoNT-pro-
ducing clostridia (McCroskey & Hatheway, 1988; McCroskey et al., 1991; Griffin 
et al., 1997; Fenicia et al., 1999). The healthy human gut microbial population 
does not contain C. botulinum (Hatheway & McCroskey, 1987; Midura, 1996; 
Stark & Lee, 1982), but environmental spores of C. botulinum that have reached 
the adult intestines may proliferate when the protective microbial population 
is absent. In addition, a potential association between the presence of Meckel’s 
diverticulum and colonization of C. botulinum in adult and infant intestines has 
been reported (Aureli et al., 1986; Fenicia et al., 1999; Schechter & Arnon, 1999).
Aerosolized BoNT accidentally caused inhalation botulism in three veter-
inarians in West Germany. They were exposed to BoNT/A by the inhalation 
route while performing necropsy on laboratory animals with BoNT/A-coated 
fur (Holzer, 1966; Arnon et al., 2001). The potential use of aerosolized BoNT 
as a bioweapon is a substantial threat. For instance, the Japanese cult Aum 
Shinrikyo attempted to use aerosolized BoNT in Tokyo as a terrorist act (Ar-
non et al., 2001). 
Iatrogenic botulism may be caused by cosmetic or therapeutic injection of 
commercialized BoNT. Intramuscular injections to treat muscle disorders and 
unlicensed BoNT have been reported to cause botulism (Girlanda et al., 1992; 
Bakheit et al., 1997; Sobel, 2005)
2.2 Importance of C. botulinum in the food industry
Occurrence of foodborne botulism lies on a series of incidents that follow con-
tamination of foodstuffs with C. botulinum spores or vegetative cells, survival 
through food processing or postprocessing contamination, outgrowth, and toxin 
production in the food during storage, and conclusively, consumption of food 
without cooking to destroy BoNT (Eklund, 1992). Due to the ubiquitous presence 
of C. botulinum in the environment, it is generally impracticable to prevent the 
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organism from contaminating raw food materials. Therefore, hygienic practices 
should be employed to keep the contamination level as low as possible (Jungho 
& Foegeding, 1992). 
Foods contaminated by C. botulinum spores pose diverse patterns of risk in 
food processing and safety, due to physiologic differences between strains of 
Group I and II C. botulinum (Lindström et al., 2006b). Traditionally, Group I 
strains are associated with home-canned or fermented foods (Hauschild, 1992). 
To overcome the safety hazard by Group I C. botulinum in the canning pro-
cess, ’botulinum cook’ (121.1 °C for 3 min) has been adopted to eradicate the 
risk by a factor of 1012 (Stumbo et al., 1975). However, homemade or commer-
cialized canned foods when inadequately processed may contain viable spores 
and cause foodborne botulism (Peck, 1997; Peck & Stringer, 2005). Growth of 
proteolytic Group I strains has not been reported below 10 °C, hence proper 
storage temperatures will prevent growth and toxin formation by these strains 
in foods. However, temperature abuse during storage has caused botulism re-
lated to Group I C. botulinum in commercially produced foods (Chou et al., 
1988; Louis et al., 1988; Angulo et al., 1998; Aureli et al., 2000; Kalluri et al., 
2003; Jalava et al., 2011). Alarmingly, foodborne botulism may also occur when 
BoNT-containing foodstuffs are mixed with other foods that are properly stored 
(O’Mahony et al., 1990; Angulo et al., 1998). 
Consumer demand for mildly treated foods that contain fewer preservatives 
has led to the emergence of refrigerated processed food of extended durabili-
ty (REPFED). REPFEDs are rapidly cooled after a heat treatment step with a 
temperature range of 65–95 °C and stored at refrigeration temperatures (1–8 
°C) (Peck, 1997). A shelf life is set, based on the processing and storage tem-
peratures, pH, aw, properties of the ingredients, and packaging. Correct storage 
at refrigeration temperatures will eliminate the risk related to Group I C. bot-
ulinum. In contrast, these temperatures are not sufficient to remove the food 
safety hazard caused by Group II C. botulinum (Table 1), especially when vacu-
um packaging is applied. A high prevalence of Group II C. botulinum has been 
reported in fish and fishery products (Hyytiä et al., 1998). The mild processing 
temperatures of such products are often not enough to eliminate all Group II 
C. botulinum spores (Lindström et al., 2003), thus allowing probable hazards 
when the storage temperature is abused. Particularly, failure in the storage 
temperature of vacuum-packaged hot-smoked fish products has been reported 
to cause foodborne botulism (Korkeala et al., 1998; Lindström et al., 2006a; 
King et al., 2009). Therefore, REPFEDs should not be stored at temperatures 
higher than 3 °C (Lindström et al., 2006b; Peck, 2006). 
Chilled storage is often the only barrier to control BoNT formation by C. bot-
ulinum in foods (Peck, 2006). However, storage temperatures in home refriger-
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ators and retail stores may exceed 10 °C (Evans, 1998). Therefore, multibarrier 
measures should be used in case one measure fails to prevent the growth and 
BoNT formation by C. botulinum in foods (Peck & Stringer, 2005). The use of 
factors that affect the growth of C. botulinum in foods, combinations of these 
factors, and predictive models have been extensively studied (Baird-Parker & 
Freame, 1967; Graham & Lund, 1986, 1987; Lund et al., 1990; Graham et al., 
1997; Hyytiä et al., 1997, 1999a; Skinner & Larkin, 1998; Hyytiä-Trees et al., 
2000; Carlin et al., 2000; Lindström et al., 2001a, 2003; Barker et al., 2002; 
Peck et al., 2008; Malakar et al., 2011; Selby et al., 2011; Keto-Timonen et al., 
2012). The Advisory Committee on the Microbiological Safety of Foods has 
recommended storage at: (i) < 3 °C; (ii) ≤ 5 °C with shelf life of ≤ 10 d; (iii) 
5–10 °C with shelf life ≤ 5 d; (iv) 8 °C combination of heat treatment of 90 °C 
for 10 min or equivalent lethality; (v) 8 °C with combination of pH ≤ 5.0 or salt 
concentration ≥ 3.5% throughout the food or aw ≥ 0.97 throughout the food to 
establish the safety of REPFEDs with respect to Group II C. botulinum (Peck & 
Stringer, 2005). Although rare, when a botulism outbreak due to spoiled com-
mercial foods occurs, the medical and economic losses may be as much as $30 
million per case in the United States, which can dramatically affect the food 
industry and society (Setlow & Johnson, 1997). 
2.3 Stress response in C. botulinum
2.3.1 Temperature stress 
Temperature represents a critical environmental parameter that microorgan-
isms encounter. Change in the temperature can lead to alterations in growth 
and pathogenesis (Shapiro & Cowen, 2012). Therefore, organisms readjust their 
physiology to respond to sudden temperature shifts. When the changes in the 
ambient temperature become harmful, cells mediate defensive heat- or cold-
shock responses (Klinkert & Narberhaus, 2009).
Heat-shock response
Elevated temperatures compromise the metabolism, due to misfolding, denatur-
ation, and aggregation of proteins, disruption in the structure of the cytoplasmic 
membrane, and damage in the nucleic acids (Schumann, 2003; Laskowska et al., 
2004; Guisbert et al., 2008; Guisbert & Morimoto, 2013). During heat shock, 
the corresponding response of bacterial cells is up-regulation of a set of genes 
called heat-shock genes (HSGs), hence increased synthesis of heat-shock pro-
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teins (HSPs) (Schumann, 2003; Guisbert et al., 2008). A large number of these 
HSPs exhibit highly conserved primary structures, indicating that they conduct 
similar functions in all organisms (Schumann, 2003; Shapiro & Cowen, 2012). 
The HSGs are categorized into different classes, depending on the transcriptional 
regulator that regulates their expression. These regulators could be an alternative 
sigma factor, a transcriptional activator, or a transcriptional repressor (Hecker 
et al., 1996; Schumann, 2003; Klinkert & Narberhaus, 2009). One of the two 
most common HSPs is the group of molecular chaperons that maintain correct 
folding and assembly of polypeptides in the cell, while the other is adenosine 
triphosphate (ATP)-dependent proteases that degrade the misfolded proteins 
that are unable to refold into their intrinsic structure (Georgopoulos & Welch, 
1993; Gottesman, 1996). In addition, HSGs, especially molecular chaperons, 
are also expressed at ambient temperature, indicating their importance during 
exponential growth when large amounts of proteins are newly synthesized and 
their proper folding is essential (Hartl & Hayer-Hartl, 2002; Schumann, 2003; 
Selby et al., 2011).
In C. botulinum, alteration of gene expression pattern and protein synthe-
sis has been documented in heat shock (Shukla & Singh, 1999, 2009; Selby 
et al., 2011; Liang et al., 2013). The HSG (37–45 °C) expression profile of 
C. botulinum American Type Culture Collection (ATCC) 3502 revealed that 
176 genes were differentially expressed over a period of 15 min (Liang et al., 
2013). The overexpressed genes included HSP-encoding genes of the dnaK 
operon, groE operon, hsp20, and htpG and the down-regulated genes were 
among the aminoacyl-transfer RNA (tRNA) synthetase genes and ribosomal 
and cell division protein genes (Liang et al., 2013). A previous study made 
similar observations for the dnaK and groE operons after heat shock and 
even for a longer experimental time frame (Selby et al., 2011). Furthermore, 
the mutational inactivation of dnaK and the negative regulator of the dnaK 
operon, the hrcA gene, have resulted in heat-sensitive phenotypes (Selby et 
al., 2011). 
In the Gram-positive model organism Bacillus subtilis, growth delay was 
reported after heat shock (Schulz & Schumann, 1996). In contrast, no such 
delay was monitored in C. botulinum following heat shock, but permitted the 
culture to enter the stationary growth phase at a lower cell density (Selby et al., 
2011). Furthermore, the HSGs of C. botulinum, particularly the dnaK operon, 
are up-regulated for a longer time than those of B. subtilis after heat shock 
(Wetzstein et al., 1992; Selby et al., 2011). The SigB-dependent general stress 
regulon that is a capital actor in the heat and general stress response of B. sub-
tilis and other Gram-positive bacteria (Hecker et al., 2007) does not appear to 
exist in C. botulinum (Sebaihia et al., 2007). This may be one of the reasons 
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that C. botulinum and other clostridia lacking SigB-dependent stress regulons 
express their HSGs for a longer time than B. subtilis during heat shock (Nar-
berhaus et al., 1992; Narberhaus & Bahl, 1992; Wetzstein et al., 1992; Selby et 
al., 2011;), hence promote faster heat-shock recovery of C. botulinum than B. 
subtilis (Schulz & Schumann, 1996). 
The effect of heat stress on the expression and production of BoNT is one of 
the important aspects in food safety and processing. Liang et al. (2013) reported 
no significant induction of toxin cluster genes after heat shock in C. botulinum 
when a twofold increase in the expression level was set as the cutoff point (Liang 
et al., 2013). On the other hand, Shukla and Singh (2009) reported enhanced 
production of a 33-kDa HA component (HA33) of the BoNT complex during 
heat shock and proposed that HA33 is an HSP.
Cold-shock response
When an exponentially growing bacterial culture at its optimum growth tem-
perature is exposed to a rapid temperature downshift, the growing cell cul-
ture generally undergoes a growth arrest. The sudden temperature decrease 
in the environment affects the membrane-associated transport and secretion 
mechanisms, reduces membrane fluidity, hampers efficient transcription and 
translation by stabilization of the secondary structures of nucleic acids, leads 
to less competent ribosomal machinery than at optimum growth temperature 
and improper protein folding, and perturbs enzymatic activity in the cell (Bae 
et al., 2000; Weber & Marahiel, 2003; Phadtare, 2004). The growth arrest al-
lows cells to adapt and alter their protein synthesis accordingly to cold stress. 
At this repressed growth phase, general protein synthesis is dramatically in-
hibited, but synthesis of cold-induced proteins (CIPs) and cold acclimatization 
proteins (CAPs) are increased (Weber & Marahiel, 2003). Finally, production 
of CIPs decreases and the acclimated cells resume growth. The CIPs are the 
prompt response to cold shock and are transiently induced, whereas CAPs are 
constantly present at high levels in the cold-shocked cells (Jones et al., 1987; 
Weber & Marahiel, 2003; Phadtare, 2004). 
Cold shock induces the expression of a set of highly conserved small proteins 
called cold-shock proteins (CSPs). At suboptimal temperatures, ribonucleic acid 
(RNA) secondary structures become stable, thus decelerate transcription elon-
gation and motion of ribosomes on RNA (Phadtare, 2004). These transiently 
induced CSPs appear to be RNA chaperons that bind single-stranded RNA, 
hence destabilize the RNA secondary structures and regulate ribosomal trans-
lation, rate of RNA degradation, and termination of transcription (Ermolenko 
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& Makhatadze, 2002; Horn et al., 2007). In Group I C. botulinum, three CSPs 
(CspA–C) have been identified and cspB has been proposed to encode the ma-
jor Csp (Söderholm et al., 2011). Furthermore, transcriptomic analysis of the 
cold-shock response of C. botulinum indicated a significant induction of the 
CspA- and CspB-encoding genes (Dahlsten et al., 2014a). 
 Modification of the structure/function of nucleic acids and translation ma-
chinery, and alteration of composition of the cell membrane, probably constitute 
the shared cold- shock response strategy in a wide variety of organisms (Panoff 
et al., 1998; Hébraud & Potier, 1999; Los & Murata, 1999; Cavicchioli et al., 
2000). During cold shock, the elastic liquid-crystalline state of the membrane 
changes to a rigid gellike state that results in reduced lipid molecular dynamics 
(Weber & Marahiel, 2003; Shivaji & Prakash, 2010). Bacteria confront this effect 
by changing the lipid composition from saturated fatty acid (FA) to an increased 
proportion of unsaturated FA in the membrane, thus restoring fluidity (Suutari 
& Laakso, 1994; Russell et al., 1995). The two major ways of achieving this mod-
ification are through de novo synthesis of unsaturated FAs (Suutari & Laakso, 
1994) and desaturation of existing FAs (Los & Murata, 1998; Weber & Marahiel, 
2003). An example of the latter is the des gene, coding for oxygen-dependent 
Δ5-desaturase, which is under the control of a cold-inducible two-component 
system (TCS), DesK/DesR, that has been identified in B. subtilis (Aguilar et 
al., 1998, 1999, 2001; Altabe et al., 2003). It is likely that the physicochemical 
state of the membrane is utilized as a thermosensor by cells in which change 
in the lipid domains that surround the membrane-embedded DesK activates 
this protein, thus phosphorylating the cognate response regulator (RR) DesR. 
Subsequently, the phosphorylated DesR induces expression of Δ5-desaturase 
(Aguilar et al., 2001; Weber & Marahiel, 2003). The oxygen-dependent lipid 
desaturase system (Altabe et al., 2003) is of limited use to aerobic bacteria. 
Nevertheless, membrane-mediated temperature sensing through the TCS may 
also be used by C. botulinum. In fact, a cold-induced TCS, CBO0366/CBO0365, 
has been reported in C. botulinum ATCC 3502 and mutational analysis indi-
cated its importance in the cold-shock response (Lindström et al., 2012). In 
C. botulinum, which is strictly anaerobic, strong induction of FA biosynthesis 
genes has been reported after cold shock (Dahlsten et al., 2014a), and increased 
levels of unsaturated FA have been observed when the growth temperature is 
lowered from 37 °C to 8 °C (Russell et al., 1995). In addition, temperature-de-
pendent adjustment of the membrane lipid composition has been reported in 
Group II C. botulinum (Evans et al., 1998). However, the system behind this 
modification is unknown.
Another mechanism employed by bacteria to overcome cold stress-related 
disruption of RNA metabolism is bacterial DEAD-box helicases which are in-
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volved in destabilization of cold-induced RNA secondary structures (Vakulskas 
et al., 2014). The importance of DEAD-box helicases in cold stress has been 
documented in the Gram-positive model organism B. subtilis (Hunger et al., 
2006) and in foodborne pathogens such has Listeria monocytogenes (Markkula 
et al., 2012a), Yersinia pseudotuberculosis (Palonen et al., 2012), and Bacillus 
cereus (Pandiani et al., 2010).
An important factor in the general stress response is alternative sigma fac-
tor SigB (Hecker et al., 2007), which plays an important role in cold stress in 
Gram-positive B. subtilis (Brigulla et al., 2003) and L. monocytogenes (Becker 
et al., 2000). Although the homologue for SigB is absent in C. botulinum, a 
sporulation sigma factor homologue of bacilli, SigK, is present (Sebaihia et al., 
2007) and plays an important role in cold adaptation (Dahlsten et al., 2013).
An additional strategy of bacteria for overcoming cold stress is to accumu-
late low-molecular-weight molecules, such as polyols, polyamines, sugars, and 
amino-acid derivatives. These molecules are called compatible solutes and they 
protect cells from cold or hyperosmotic stress by preventing denaturation and 
aggregation of proteins (Shivaji & Prakash, 2010). Compatible solutes such as 
trehalose, glycine betaine, and carnitine have been reported to accumulate in B. 
subtilis (Hoffmann & Bremer, 2011), L. monocytogenes (Ko et al., 1994; Bayles 
& Wilkinson, 2000), and Escherichia coli (Kandror et al., 2002) during osmotic 
and cold stress. In C. botulinum, compatible solute uptake mechanisms and 
putative choline/carnitine/betaine transporter are significantly induced after 
cold shock, while incorporation of glutamic acid, arginine, and lysine may be 
utilized as compatible solutes by C. botulinum ATCC 3502 under cold stress 
(Dahlsten et al., 2014a).
2.3.2 NaCl, pH, and ethanol stress
Apart from varying temperatures, bacteria are consistently exposed to stressful 
chemical and physical changes in their environment. To survive, they must be 
able to endure these harsh conditions. Various stress factors are used in the 
food industry to control the growth of or eliminate microorganisms to ensure 
food safety. Addition of salts and fermentation of foods are some of the widely 
used methods to preserve foods (Roeßler & Müller, 2001).
Addition of salts to foods or events in bacterial natural habitats that reduce 
aw results in increased external osmolality. Reduction in aw has a dramatic ef-
fect on lag phase, growth rate, and membrane lipid composition (Russell et al., 
1995; Cheroutre-Vialette et al., 1998). Furthermore, the presence of salt inhibits 
active transport systems and DNA replication (Roth et al., 1985; Beales, 2004). 
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Under low-aw conditions, bacterial cells reconstitute turgor pressure by taking 
up potassium ions or aggregating or synthesizing compatible solutes. These 
aggregate without compromising the core cell mechanisms and restore osmot-
ic equilibrium, hence maintain cell volume, shape, and physiological functions 
(Whatmore et al., 1990; Welsh, 2000; Nagata et al., 2002). Effective responses 
to osmotic stress require bacteria to sense and convert physicochemical stimuli 
into a signal that is further processed and ultimately leads cells to adapt new 
physiological steady-state situations (Krämer, 2010). Such signal transduction 
systems that are involved in osmosensing include EnvZ/OmpR and KdpD/KdpE 
in E. coli and MtrA/MtrB in Corynebacterium glutamicum (Leonardo & Forst, 
1996; Walderhaug et al., 1992; Möker et al., 2004).
Fermentation processes generate organic acids, alcohol, and carbon dioxide, 
which inhibit the growth of pathogenic bacteria (Cotter & Hill, 2003). Moreover, 
addition of weak acid preservatives such as acetic, lactic, benzoic, and sorbic 
acid to the foods has growth-limiting effects on microorganisms (Brul & Coote, 
1999). Undissociated weak acids can penetrate freely through the cell mem-
brane and yield protons that acidify the interior of the cell. On the other hand, 
strong acids are not able to infiltrate through the cell membrane, but disrupt 
the function of the molecules on the cell surface. Strong acids can also lower 
the cytoplasmic pH, due to high proton permeability when the proportional 
transmembrane pH difference is high (Beales, 2004; Mols & Abee, 2011). Under 
low-pH conditions, survival of bacteria is dependent on their ability to regulate 
pH homeostasis. The mechanisms that are involved in low-pH stress include 
proton pumps, transcriptional regulators, such as SigB, molecular chaperons, 
i.e. DnaK and GroESL, and production of alkaline compounds (van de Guchte et 
al., 2002; Ryan et al., 2009; Mols et al., 2010; Mols & Abee, 2011). In addition, 
under low-pH stress, E. coli cells reportedly move away from acidic environments 
and cell elongation for Bacillus polymyxa and Clostridium tyrobutyricum has 
been observed (Everis & Betts, 2001; Beales, 2004).
The effects of NaCl and pH on growth of C. botulinum have been extensively 
studied (Graham & Lund, 1987; Lund et al., 1990; Graham et al., 1996a, 1996b, 
1997; Webb et al., 2007). However, information on the genes that are involved 
in survival and adaptation of C. botulinum in osmotic and acid stress is scarce. 
Recent studies have demonstrated the importance of sigK and hrcA in osmotic 
and the dnaK gene in both osmotic and pH stress in C. botulinum (Selby et al., 
2011; Dahlsten et al., 2013). Further research is essential to characterize ad-
ditional stress-related genes to understand the mechanisms underlying stress 
tolerance in C. botulinum. 
Exposure to ethanol primarily damages membrane permeability, protein 
denaturation, and folding, hence impairs multiple cellular functions (Ingram 
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& Buttke, 1985; Ingram, 1989; Barker & Park, 2001). Therefore, bacterial ad-
aptation strategies against ethanol stress can be seen as changes in membrane 
composition and in translation and protein-folding mechanisms (Yang et al., 
2012). Ethanol-exposed cells modify the FA composition, rigidifying the mem-
brane, since ethanol harmfully increases the fluidity (Isken & de Bont, 1998; 
Timmons et al., 2009; Seydlova et al., 2012). Moreover, recruitment of the mo-
lecular chaperons DnaK and GroEL in the cell membrane was reported under 
ethanol stress (Seydlova et al., 2012).
Addition of ethanol to growth media prolonged the lag time, decreased 
the exponential growth rate, and the final level of culture density in C. bot-
ulinum (Daifas et al., 2003). Daifas and colleagues (2003) estimated the 
growth-limiting ethanol concentration to be 5.5% w/w for C. botulinum. Fur-
thermore, they observed elongated vegetative cells under ethanol stress and 
the beneficial effect of ethanol on prolonging shelf life, especially for bakery 
products (Daifas et al., 2000; Smith et al., 2004). Nevertheless, the molecular 
mechanisms and genes behind the ethanol stress response of C. botulinum 
are not well known.
2.3.3 Stress-related genes 
Most organisms live in a dynamic environment. Survival of bacteria in an envi-
ronment with fluctuating parameters is dependent on rapid adaptation mech-
anisms. The adaptive response of bacteria is carried out by complex regulatory 
networks that control the expression of large numbers of genes. Since the stress 
response comprises the regulation of a great number of genes, emphasis is only 
given on the genes below. 
Cold-shock protein-encoding genes
The csp genes encode a family of conserved small (approx. 70 amino ac-
ids) proteins, most members of which are highly induced after cold shock 
(Phadtare et al., 1999). The CSPs are abundant in psychrophilic, mesophilic, 
thermophilic, and hyperthermophilic bacteria (Weber et al., 2002). They pose 
two nucleic-acid-binding motifs, ribonucleoprotein (RNP) 1 and 2, hence bind 
to single-stranded nucleic acids (Ermolenko & Makhatadze, 2002). Under 
low-temperature stress, RNA becomes highly stable and secondary struc-
ture formation is increased. CSPs act as RNA chaperones that bind to melt 
cold-generated RNA secondary structures, thus restoring transcription and 
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translation at low temperature (Horn et al., 2007; Phadtare & Severinov, 
2010).
Mesophilic E. coli harbors nine CSPs (CspA–I) but only CspA, CspB, CspG, 
and CspI are cold-shock-inducible (Ermolenko & Makhatadze, 2002; Phadtare & 
Severinov, 2010). While CspC and CspE are constitutively expressed (Yamanaka 
et al., 1994), CspD is expressed at the stationary growth phase and under nutri-
tional starvation (Yamanaka & Inouye, 1997). The double or triple deletion of 
csp genes in E. coli has not resulted in cold-sensitive phenotypes, and CspE is 
overproduced in a triple-deletion strain (ΔcspAΔcspBΔcspG) (Xia et al., 2001; 
Phadtare, 2004). However, the quadruple-deletion strain lacking cspA, cspB, 
cspE, and cspG is cold-sensitive and overexpression of csp genes, except cspD, 
restored cold sensitivity (Xia et al., 2001). Therefore, it has been suggested 
that CSPs may have overlapping cellular functions (Ermolenko & Makhatadze, 
2002; Weber & Marahiel, 2003). In B. subtilis, three CspA-like proteins named 
CspB, CspC, and CspD have been found (Graumann et al., 1996; Kunst et al., 
1997), and the presence of at least one CSP is essential for viability at optimum 
growth temperature (Graumann et al., 1997). Furthermore, double deletion of 
cspB and cspC leads to cell lysis at the stationary growth phase, and mutants 
lacking functional cspB and cspC or cspB and cspD have lost the ability to 
form spores (Weber et al., 2001a, 2001b; Weber & Marahiel, 2003;). Therefore, 
cold-inducible CSPs also play important roles under noncold-shock conditions.
The Clostridium botulinum ATCC 3502 genome contains three CSP-encod-
ing genes (cspA, cspB, and cspC) (Sebaihia et al., 2007). During cold shock, 
significant inductions were reported for cspA and cspB, but not for cspC, in C. 
botulinum ATCC 3502 (Dahlsten et al., 2014a). Similarly, significant increases 
in relative expression level have been observed for cspB, and further muta-
tional analysis indicated that cspB encodes the major CSP, while cspC plays a 
role both under cold and optimal growth conditions (Söderholm et al., 2011). 
On the other hand, the mutant strain with disrupted cspA grows slightly bet-
ter than the wild-type strain at optimum and low temperatures (Söderholm et 
al., 2011). Intriguingly, no homologues for CSP-encoding genes were found in 
psychrotrophic Group II C. botulinum (Söderholm et al., 2013).
In addition to cold shock, CSPs play a role in osmotic (Schmid et al., 2009), 
oxidative (Loepfe et al., 2010), and global stress regulation (Phadtare & Inouye, 
2001). Moreover, functions in antibiotic biosynthesis (Martínez-Costa et al., 
2003), ultraviolet (UV) sensitivity (Mangoli et al., 2001), production of liste-
riolysin O (Schärer et al., 2013), tolerance to solvents and camphor resistance 
have been attributed to CSPs (Hu et al., 1996; Segura et al., 2005). To date, 
no reports are available on involvement of CSP-encoding genes other than in 
temperature stress in C. botulinum.
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Two-component systems
 To maintain effective responses to physicochemical deviations in the environ-
ment, organisms are equipped with specific signaling mechanisms (Eriksson et 
al., 2002). The central mechanism in bacteria transforming environmental devi-
ations into a regulatory output is the TCS (Krell et al., 2010). The TCS-encoding 
genes are present in Archaea, Eubacteria, also in several eukaryotes, and are 
found in most of the sequenced genomes of bacteria, but absent in mammals, 
which makes them potential targets for novel antibacterials (Schreiber & Matter, 
2009; Wuichet et al., 2010; Liu et al., 2014).
The prototypical TCSs consist of two major components, a membrane-asso-
ciated sensor histidine kinase (HK) and its cytoplasmic cognate RR (Cheung et 
al., 2005). In a typical signaling cascade, HK monitors environmental stimuli 
and transfers the signal to the RR through phosphorylation (Stock et al., 2000). 
The HK and RR can further be categorized into sensor and transmitter domains 
in HK and receiver and output domains in the RR (Krell et al., 2010). The sen-
sor domain of HK is connected by a transmembrane region to its transmitter 
domain. The engagement of environmental stimuli can activate combination 
of sliding and rotational movements of the membrane-embedded connector 
region, which then initiates activation of HK (Casino et al., 2010; Cheung & 
Hendrickson, 2010). On activation, HK undergoes ATP-dependent autophos-
phorylation at a conserved histidine residue within the transmitter domain. The 
receiver domain of RR then catalyzes the transport of the phosphoryl group to 
its aspartate residue. The phosphotransfer to the RR triggers conformational 
changes in the downstream output domain, which conducts specific responses 
via DNA binding (West & Stock, 2001; Casino et al., 2010; Gao & Stock, 2010). 
The transmitter of HK and the receiver domain of the RR are conserved, whereas 
the sensor and output domains vary in sequence, indicating that they emerge 
to sense specific signals and modulate the response accordingly (Dutta et al., 
1999; Gao & Stock, 2009; Bourret & Silversmith, 2010). 
Although for many TCSs, the direct physiological signal that triggers the ac-
tion of TCS remains unknown, TCSs play a central role in tolerance to different 
stresses. The EnvZ/OmpR and KdpD/KdpE of E.coli are involved in osmotic, 
DesK/DesR and CssR/CssS of B. subtilis function in low-temperature, and heat 
and secretion stress, respectively (Aguilar et al., 2001; Darmon et al., 2002; 
Cai & Inouye, 2002; Freeman et al., 2013). Moreover, the LisKR system in L. 
monocytogenes is important for multiple stress conditions, including tempera-
ture, acid, osmotic, and ethanol stress (Cotter et al., 1999; Kallipolitis & Ingmer, 
2001; Sleator & Hill, 2005; Chan et al., 2008). It was also reported that the RR 
DegU of L. monocytogenes is involved in regulation of temperature-dependent 
motility (Knudsen et al., 2004; Gueriri et al., 2008). In Y. pseudotuberculosis, 
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a large number of predicted TCS genes have been significantly induced at low 
temperature and the TCS CheA/CheY is crucial for low-temperature growth 
and motility (Palonen et al., 2011) 
In clostridia, VirS/VirR is involved in the regulation of virulence of Clos-
tridium perfringens (Lyristis et al., 1994; Shimizu et al., 1994; Ma et al., 2011) 
and Clostridium acetobutylicum possesses a homologue of the KdpD/KdpE 
system (Cheung et al., 2005). In C. botulinum ATCC 3502, the importance of 
CBO0366/0365 has been documented, since the genes encoding this system 
were significantly induced and growth of mutants with insertional inactivation 
of these genes was impaired at low temperature (Lindström et al., 2012). Fur-
thermore, transcriptomic analysis of a mutant with an insertionally inactivated 
RR encoded by the cbo0365 gene indicated that acetone-butanol-ethanol fer-
mentation, resistance to arsenic, and phosphate uptake metabolism are directly 
regulated by the TCS CBO0366/0365, and these metabolisms play a role in cold 
tolerance of C. botulinum ATCC 3502 (Dahlsten et al., 2014b). 
TCSs also affect the growth kinetics of and highly regulated BoNT production 
in C. botulinum (Connan et al., 2012; Zhang et al., 2013a), and the CBO0787/
CBO0786 system negatively regulates BoNT expression by binding to the pro-
moters of the ha and ntnh-botA operons in C. botulinum ATCC 3502 (Zhang 
et al., 2013a). The genomes of Group I C. botulinum ATCC 3502 and Group II 
Beluga strain contain approximately 30 putative TCSs each (Sebaihia et al., 2007; 
Ulrich & Zhulin, 2010). Therefore, it is plausible that C. botulinum may be using 
multiple TCSs to respond to environmental stress that are yet to be discovered.
DEAD-box RNA helicase
RNA helicases are ubiquitous among organisms from bacteria to humans, and 
they utilize ATP to bind or remodel RNA or RNP complexes (Tanner & Linder, 
2001; Vakulskas et al., 2014). The DEAD-box RNA helicases are members of the 
highly conserved DEAD-box (aspartic acid-glutamic acid-alanine-aspartic acid) 
protein family, and they are induced at low temperatures (Jones et al., 1996; 
Markkula et al., 2012a, 2012b; Palonen et al., 2012; Dahlsten et al., 2014a).The 
DEAD-box RNA helicases function in messenger RNA (mRNA) processing and 
decay, ribosome biogenesis, and translation initiation (Lu et al., 1999; Charollais 
et al., 2004; Iost & Dreyfus, 2006). Moreover, they function in the regulation 
of expression of CSPs at low temperature (Jones et al., 1996; Yamanaka & 
Inouye, 2001).
The DEAD-box RNA helicases are some of the actors that play important 
roles in bacterial stress responses and starvation, since they are involved in RNA 
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metabolism (Takayama & Kjelleberg, 2000). In L. monocytogenes, deletion of 
DEAD-box RNA helicase genes resulted in reduced growth rate and restricted 
motility at low temperatures, and these mutants had higher minimum growth 
temperatures than the wild-type strain (Markkula et al., 2012a). Furthermore, 
DEAD-box RNA helicase-encoding genes participate in tolerance to heat, alkali, 
ethanol, and oxidative stress (Markkula et al., 2012b). Similarly, involvement 
of DEAD-box RNA helicases in temperature, pH, and oxidative stress has been 
documented in B. cereus (Pandiani et al., 2011). In another foodborne pathogen, 
Y. pseudotuberculosis, impaired growth was observed for strains with insertional 
inactivation of the csdA under cold stress (Palonen et al., 2012).
The only information available on the DEAD-box RNA helicase gene of C. 
botulinum is a rapid and significant expression of this gene after cold shock that 
is determined by microarray analysis (Dahlsten et al., 2014a). This observation 
suggests that DEAD-box RNA helicase plays a role in cold stress response of C. 
botulinum. However, this hypothesis has not been characterized. 
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3  AIMS OF THE STUDY
The objectives of this thesis were to investigate the strain variation in growth of 
Group II C. botulinum at extreme temperatures, stress response of Group I and 
Group II C. botulinum, and to explore the molecular machinery underlying the 
stress response that plays roles in survival and adaptation in food processing 
and during storage of this foodborne pathogen. 
The specific objectives were as follows:
1. To evaluate the strain variation within Group II C. botulinum at high and 
low temperatures (I). 
2. To evaluate the involvement of CSP-encoding genes in NaCl, pH, and ethanol 
stress and motility in Group I C. botulinum ATCC 3502 (II).
3. To investigate the importance of the TCS CBO2306/CBO2307 in Group 
I C. botulinum ATCC3502 and CLO3403/3404 in Group II C. botulinum 
Beluga regarding cold tolerance (III, IV).
4. To investigate the role of cbo2802 RNA helicase in growth at suboptimal 
temperature and motility in Group I C. botulinum ATCC 3502 (V).
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4  MATERIALS AND METHODS
4.1 Strains (I–V)
Twenty-four Group II C. botulinum strains were used (I). Three of these strains 
were toxin-type B, 16 type E, and 5 type F (Table 2). The strains were selected, 
based on their distinct genetic backgrounds determined with various typing 
methods (Hielm et al., 1998b; Hyytiä et al., 1999c). Group I C. botulinum ATCC 
3502 and single insertional mutants derived from this strain were used (II, III, 
and V), as were the Group II C. botulinum Beluga strain and single insertional 
mutants derived from this strain (IV) (Table 2). 
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Table 2. Clostridium botulinum strains and plasmids used in this study.
Strains and plasmids Description/Toxin type Source
Strains
ATCC3502 NDa/A ATCCb
Eklund 17 Marine sediment/B ATCC
BL 93/6 Human/B IFRc
BL 90/4d ND/B ATCC
K3 Rainbow trout surface/E DFHEHe
K8 d Rainbow trout intestines/E DFHEH
K35 d Vendace/E DFHEH
K36 Rainbow trout/E DFHEH
K42 Rainbow trout intestines/E DFHEH
K44 Rainbow trout intestines/E DFHEH
K51 d Rainbow trout surface/E DFHEH
K101 Chub surface/E DFHEH
K117 Whitefish/E DFHEH
K119 Rainbow trout intestines/E DFHEH
K125 Rainbow trout roe/E DFHEH
BL 93/8 Human/E IFR
31-2570 d ND/E DFHEH
BL81/26 (Beluga) Beluga flipper/E IFR
S16 Fishpond sediment/E DFHEH
CB11/1-1 Whitefish roe/E DFHEH
202 d Marine sediment/F ATCC
BL86/32 d ND/F IFR
BL86/33 ND/F IFR
BL86/34 d ND/F IFR
610B8-6 Salmon/F Craig, Lindroth f
cspA mutant
Insertional mutant of cbo0282 in antisense directi-
on at position 58-59/A 
Söderholm et al. 
2011
cspB mutant
Insertional mutant of cbo1387 in antisense directi-
on at position 74-75/A
Söderholm et al. 
2011
cspC mutant
Insertional mutant of cbo1772 in sense direction at 
position 54-55/A
Söderholm et al. 
2011
cbo2306s
Insertional mutant of cbo2306 in sense direction at 
position 879-880/A  III
cbo2306a
Insertional mutant of cbo2306 in antisense directi-
on at position 114-115/A  III
cbo2307s
Insertional mutant of cbo2307 in sense direction at 
position 150-151/A  III
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cbo2307a
Insertional mutant of cbo2307 in antisense directi-
on at position 283-284/A  III
clo3403s
Insertional mutant of clo3403 in sense direction at 
position 630-631/E  IV
clo3403a
Insertional mutant of clo3403 in antisense directi-
on at position 227-228/E  IV
clo3404s
Insertional mutant of clo3404 in sense direction at 
position 384-385/E  IV
clo3404a
Insertional mutant of clo3404 in antisense directi-
on at position 505-506/E  IV
WT-pMTL82151 Beluga with empty shuttle plasmid vector/E  IV
clo3403s-pMTL82151 clo3403s with empty shuttle plasmid plasmid/E  IV
clo3403a-pMTL82151 clo3403a with empty shuttle plasmid plasmid/E  IV
clo3404s-pMTL82151 clo3404s with empty shuttle plasmid plasmid/E  IV
clo3404a-pMTL82151 clo3404a with empty shuttle plasmid plasmid/E  IV
WT-
pMTL82151::clo3404-
clo3401 WT with complementation plasmid/E  IV
clo3403s-
pMTL82151::clo3404-
clo3401 clo3403s with complementation plasmid/E  IV
clo3403a-
pMTL82151::clo3404-
clo3401 clo3403a with complementation plasmid/E  IV
clo3404s-
pMTL82151::clo3404-
clo3401 clo3404s with complementation plasmid/E  IV
clo3404a-
pMTL82151::clo3404-
clo3401 clo3404a with complementation plasmid/E  IV
cbo2802s
Insertional mutant of cbo2802 in sense direction at 
position 937-938/A  V
cbo2802a
Insertional mutant of cbo2802 in antisense directi-
on at position 221-222/A  V
Plasmids
pMTL007 ClosTron vector for mutagenesis Heap et al. 2007
pMTL82151 Shuttle plasmid vector Heap et al. 2009
pMTL007C-E2 ClosTron vector for mutagenesis Heap et al. 2010
pMTL007::Cbo-
cspA-58a
pMTL007C-E2 targeting cbo0282 in antisense 
direction
Söderholm et al. 
2011
pMTL007::Cbo-cspB-
74a
pMTL007C-E2 targeting cbo1387 in antisense 
direction
Söderholm et al. 
2011
pMTL007::Cbo-cspC-
74s pMTL007C-E2 targeting cbo1772 in sense direction
Söderholm et al. 
2011
pMTL007C-
E2::cbo2306-879s
pMTL007C-E2 targeting cbo2306 in sense direc-
tion  III
pMTL007C-
E2::cbo2306-114a
pMTL007C-E2 targeting cbo2306 in antisense 
direction  III
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pMTL007C-
E2::cbo2307-150s pMTL007C-E2 targeting cbo2307 in sense direction  III
pMTL007C-
E2::cbo2307-283a
pMTL007C-E2 targeting cbo2307 in antisense 
direction  III
pMTL007C-
E2::clo3403-631s pMTL007C-E2 targeting clo3403 in sense direction  IV
pMTL007C-
E2::clo3403-228a
pMTL007C-E2 targeting clo3403 in antisense 
direction  IV
pMTL007C-
E2::clo3404-385s pMTL007C-E2 targeting clo3404 in sense direction  IV
pMTL007C-
E2::clo3404-506a
pMTL007C-E2 targeting clo3404 in antisense 
direction  IV
pMTL82151::clo3404-
clo3401
Complementation plasmid containing the operon 
of the TCS CLO3403/CLO3404  IV
pMTL007C-
E2::cbo2802-937s
pMTL007C-E2 targeting cbo2802 in sense direc-
tion  V
pMTL007C-
E2::cbo2802-221a
pMTL007C-E2 targeting cbo2802 in antisense 
direction  V
a No data., b American Type Culture Collection., c Culture Collection of the Institute of Food Research, 
Norwich, UK., d Previously analyzed., e Department of Food Hygiene and Environmental Health., f The 
strain have been collected by Seppo Lindroth (University of California, Davis). The preceding name 
denotes the original source, i.e., the person who presumably first isolated the strain.
4.2  Culture preparation (I–V)
All C. botulinum strains were streaked on blood agar plates (5% bovine blood 
per liter of agar) and incubated for 2–3 d at 37 °C (Group I strains) or 30 °C 
(Group II strains). A single colony was picked up and cultivated in 10-ml aliquots 
of tryptone-peptone-glucose-yeast extract (TPGY) broth (50 g/l of tryptone, 5 
g/l peptone, 4 g/l of glucose, 20 g/l of yeast extract, and 1 g/l of sodium thio-
glycollate; Difco, Becton Dickinson, Sparks, MD, USA) and incubated at 30 °C 
or 37 °C for 24 h. A volume of 100 μl of the culture was further inoculated into 
10-ml aliquots of fresh TPGY broth and incubated at 30 °C or 37 °C for 16 h. 
The overnight culture, confirmed to carry the BoNT gene by multiplex poly-
merase chain reaction (PCR) (Lindström et al., 2001b; De Medici et al., 2009), 
was diluted to optical density at 600 nm (OD600) of 1.0–1.2 with fresh TPGY. 
All cultures were prepared in an anaerobic work station (MK III; Don Whitley 
Scientific, Ltd., Shipley, UK) under atmospheric conditions of 85% N2, 10% CO2, 
and 5% H2. The agar plates and broth used in the study were deoxygenated 
before use by anaerobic storage for 48 h or 15 min of boiling, respectively. The 
experiments were repeated three times.
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4.3  Culture conditions (I–V)
The growth characteristics of the C. botulinum strains were tested at 10 °C, 30 
°C, 37 °C, and 40 °C (I), at 37 °C (II), at 15 °C and 37 °C (III and V), and at 12 
°C and 30 °C (IV) with a Bioscreen C Microbiology Reader (Oy Growth Curves 
AB, Helsinki, Finland). A 100-μl volume of Group I C. botulinum ATCC 3502 
parent and cspA, cspB, and cspC mutant strains (Söderholm et al., 2011) was 
separately inoculated into 10 ml of TPGY broth with 1.0%, 1.5%, 2.0%, 2.5%, 
3.0%, 3.5%, or 4.0% (wt/vol) NaCl; buffered TPGY with pH adjusted to 5.0, 5.5, 
6.0, 6.5, 7.0, 7.5 or 8.0; or TPGY with 1.0%, 2.0%, 3.0%, 4.0%, and 5% (wt/wt) 
ethanol (Altia Corporation, Rajamäki, Finland) (II). A 350-μl volume of each 
culture was pipetted into two or four technical replicate wells of a 100-well mi-
crotiter plate and incubated in a Bioscreen placed in an anaerobic workstation 
(MK III, Don Whitley) (Hinderink et al., 2009). The cultures were grown under 
continuous shaking for up to 14 d. The OD600 values of the cultures were mea-
sured automatically and reported at 15-min intervals by the Bioscreen Reader. 
The growth curves of the cultures were obtained by plotting OD against time. 
The maximum growth rate (optical density units (ODUs) per hour) and the lag 
phase (h) of each culture were determined by fitting the growth curves to the 
Baranyi and Roberts model (Baranyi & Roberts, 1994), using the DMfit Micro-
soft Excel program (Institute of Food Research, Norwich, UK). The experiments 
were repeated three times.
4.4  Minimum and maximum growth temperatures (I, III–V)
The minimum and maximum growth temperatures of Group I and Group II 
C. botulinum strains were determined as described by Hinderink et al. (2009), 
using the GradiplateW10 temperature gradient incubator (BCDE Group, Helsin-
ki, Finland), which was placed in an anaerobic work station. A 100-ml sample 
of each stationary phase culture was inoculated into 10 ml of TPGY broth and 
incubated at 30 °C or 37 °C to reach the midexponential growth phase. A 1-ml 
sample of each culture was then diluted (1:10) with peptone water, and 25 ml of 
diluted culture were inoculated by the droplet-run technique in a longitudinal 
direction (Mäkela & Korkeala, 1992) onto anaerobic TPGY agar plates (contain-
ing 25 g/l agar). To determine the minimum growth temperatures of Group I 
C. botulinum, the gradient was set to 15–27 °C. The temperature gradient was 
set to 3–9 °C and 33–42 °C to determine the minimum and maximum growth 
temperatures of 24 Group II strains. The growth boundaries at low temperature 
were determined with a stereomicroscope (SMZ-U; Nikon, Tokyo, Japan) after 
44
14 d for Group I and 28 d for Group II strains. The maximum temperatures were 
determined by naked eye after 48 h of incubation. The growth boundary (T) 
was determined as the margin where dense bacterial growth stopped (Mäkela 
& Korkeala, 1992) and was calculated with the following formula: T = Tlow + d 
X g, where d is the distance (in millimeters) of T to the measurement point of 
Tlow, and g is the temperature gradient generated per 1-mm interval along the 
TPGY agar plate, derived from the formula g = (Thigh - Tlow)/50 (in degrees 
Celsius per millimeter) (Hinderink et al., 2009).
4.5  AFLP analysis (I)
The amplified fragment length polymorphism (AFLP) analysis for 24 Group 
II strains was done as described by Keto-Timonen et al. (2006). The digested 
and ligated DNA samples were diluted with sterile distilled, deionized water 
(1:2) and amplified by preselective PCR (72 °C for 2 min and 20 cycles of 94 
°C for 20 s, 56 °C for 2 min, and 72 °C for 2 min) in a 20-ml reaction mixture. 
The templates were then diluted with sterile distilled, deionized water (1:20). 
Selective amplification was performed in a 10-ml reaction mixture: 94 °C for 2 
min; 1 cycle of 94 °C for 20 s, 66 °C for 30 s, 72 °C for 2 min; then the annealing 
temperature was lowered by 1 °C each cycle to 56 °C for 10 cycles, followed by 
an additional 19 cycles with an annealing temperature of 56 °C; and a final 30-
min extension at 60 °C. Selective PCR products were mixed with an internal size 
standard to enable accurate band sizing. The denatured fragments underwent 
electrophoresis with Performance Optimized Polymer 4 (POP-4) polymer (Ap-
plied Biosystems, Foster City, CA, USA) in an ABI PRISM 310 genetic analyzer 
(Applied Biosystems). The conditions for electrophoresis were 15 kV at 60 °C 
for 28 min. Eight strains (Table 2) were analyzed previously with the same 
method and instrumentation (Keto-Timonen et al., 2005) and thus were not 
reanalyzed. Data preprocessing was performed, using GeneScan 3.7 fragment 
analysis software (Applied Biosystems). AFLP pattern analysis and construction 
of a dendrogram of the 24 strains, including the aforementioned eight previously 
analyzed strains, was done using BioNumerics software, version 4.5 (Applied 
Maths, Kortrijk, Belgium).
4.6  Construction of mutants (II–V)
To construct mutants derived from the Group I and II C. botulinum strains, the 
ClosTron system was applied (Heap et al., 2007, 2010) (Table 2). In the Group 
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I C. botulinum ATCC 3502 strain, the insertions were targeted to cbo2306 in 
sense orientation at position 879-880 (cbo2306s) and in antisense orientation 
at position 114-115 (cbo2306a). In cbo2307, the insertion positions were 150-151 
(cbo2307s) and 283-284 (cbo2307a). Similarly, in cbo2802, the insertions were 
at positions 937-938 (cbo2802s) and 221-222 (cbo2802a). For mutants derived 
from the Group II C. botulinum Beluga strain, in clo3403 the insertions were 
targeted in sense orientation to position 630-631 (clo3403s) and in antisense 
orientation to position 227-228 (clo3403a). The insertions to clo3404 were 
targeted at position 384-385 (clo3404s) and at position 505-506 (clo3404a). 
The retargeting plasmids (Table 2) were either constructed (Söderholm et al., 
2011) or obtained from DNA2.0 Inc. (Menlo Park, CA, USA). The vectors were 
transferred to the recipient C. botulinum strains by conjugation from the donor 
E. coli CA434 strain (Purdy et al., 2002). The transconjugants were selected, 
using appropriate antibiotics. The successful disruption of the targeted genes 
was confirmed with primers flanking the insertion site. The insert-specific uni-
versal primer in combination with the gene-specific forward or reverse flanking 
primer were used to check the correct sense or antisense orientation. To confirm 
a single insertion event into the chromosome, Southern blotting analysis was 
used (Heap et al., 2007, 2010; Cooksley et al., 2010; Palonen et al., 2011).
4.7  Cold-shock experiment (III–V)
To observe the relative expression of cbo2306 and cbo2307 or cbo2802 in Group 
I C. botulinum ATCC 3502 or clo3403 and clo3404 in the Group II C. botulinum 
Beluga strain during optimal growth and after cold shock, overnight cultures 
grown for 16 h were inoculated into 200 or 400 ml (1:100) of fresh TPGY broth. 
The cultures were grown anaerobically at 37 °C or 30 °C until they reached 
the midexponential growth phase, and calibrator samples (t0) were collected. 
Immediately after t0, one half of the culture was cold-shocked in an ice-water 
bath by letting the culture temperature decrease from 37 °C to 15 °C or 30 °C 
to 12 °C, followed by incubation at 15 °C or 12 °C after the cold shock. The 
other half of the culture (the nonshocked control culture) was incubated at 37 
°C or 30 °C. Sampling was done simultaneously for the cold-shocked and the 
nonshocked cultures immediately (1 min) after the cold shock (t1), 30 min (t2), 
2 h (t3), and 5 h (t4) after cold shock for Group I C. botulinum ATCC 3502. 
Additional samples at 1h and 24 h were taken for the Group II C. botulinum 
Beluga strain. The samples were gently mixed with chilled stop solution (99.6% 
ethanol [Altia Corporation] and phenol [Sigma-Aldrich, St. Louis, MO, USA]) 
(1:5) and incubated on ice for 30 min. The samples were centrifuged at 4 °C. 
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The supernatant was removed, and the cell pellets were stored at -70 °C until 
RNA isolation.
4.8  RNA isolation (III–V)
The frozen cell pellets were suspended in 0.25 ml of lysis buffer containing 25 
or 50 mg/ml lysozyme, 250 IU/ml mutanolysin (all Sigma-Aldrich) in Tris-eth-
ylenediaminetetraacetic acid (EDTA) buffer (pH 8.0; Fluka Biochemica, Buchs, 
Switzerland) and incubated for 30 min or 2 h at 37 °C. Total RNA isolation 
was performed, using a spin column system (RNeasy Mini Kit; Qiagen, Hilden, 
Germany) according to the manufacturer’s instructions. Genomic DNA in the 
samples was removed by DNase treatment (RNase-free DNase set; Qiagen) 
followed by a second DNase treatment (DNA-free, Ambion, Life Technologies 
Corporation, Carlsbad, CA, USA) (Kirk et al., 2012). The RNA concentration was 
determined, using the NanoDrop ND-1000 spectrophotometer (ThermoFisher 
Scientific Inc., Waltham, MA, USA). RNA quality was checked with the Agilent 
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).
4.9  Reverse transcription-quantitative PCR analysis (RT-qPCR) 
(III–V)
The complementary DNA (cDNA) was synthesized using the DyNAmo cDNA 
synthesis kit (ThermoFisher Scientific). A total of 800 ng of RNA were re-
verse-transcribed according to the manufacturer’s instructions. The reverse 
transcription (RT) reaction was performed in duplicate for each RNA sample. 
A negative-RT control, with RT enzyme replaced by 2 μl of water, was performed 
to control DNA contamination. To investigate the relative expression of cbo2306, 
cbo2307, and cbo2802, the experiments and data analysis were carried out ac-
cording to Selby et al. (2011). The DyNAmo Flash SYBR Green quantitative PCR 
(qPCR) chemistry (ThermoFisher Scientific) was used for qPCR performed in 
the Rotor Gene 3000 Real Time Thermal Cycler (Qiagen), using the following 
cycling protocol: polymerase activation at 95 °C for 1 min, 40 cycles at 95 °C 
for 10 s and 60 °C for 20 s with data collection at the end of each cycle, and a 
final extension step for 1 min at 60 °C, followed by a melt curve analysis (from 
60 °C to 98 °C in 0.5 °C steps for 10 s). For clo3403 and clo3404, the Maxi-
ma SYBR Green qPCR Master Mix was used according to the manufacturer’s 
instructions. The run comprised one cycle at 95 °C for 10 min, followed by 40 
cycles at 95 °C for 15 s and 60 °C for 60 s, and a final cycle at 60 °C for 60 s. 
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The experiments were performed in triplicate. The 16S ribosomal RNA (rRNA) 
was used as a normalization reference and the relative expression levels were 
calculated, using the method described by Pfaffl (2001).
4.10  Complementation of mutations (IV)
The pMTL82151 plasmid (Heap et al., 2009) (Table 2) was used to complement 
clo3403 and clo3404. A fragment, 457 base pairs (bp) upstream of clo3404 
and 154 bp downstream of clo3401, containing clo3404, clo3403, clo3402, and 
clo3401, was amplified. This fragment represents the operon containing the 
TCS genes (clo3403, clo3404) and the putative natural promoter. The amplified 
genome fragments were purified from the agarose gel, using a GeneJET gel 
extraction kit and a GeneJET PCR purification kit (ThermoFisher Scientific). 
The fragments were restriction-digested with NotI and NdeI and ligated into the 
pMTL82151. Subsequently, they were purified from E. coli TOP10. The plasmids 
were sequenced, transformed into E. coli CA434, and further conjugated into 
the mutants. Appropriate antibiotics were used during the method to select for 
successful transconjugants.
4.11  Motility assay (II, IV, V)
Single colonies, grown on TPGY agar plates, were stab-inoculated with a ster-
ile inoculating loop into tubes containing TPGY agar (0.3%). The tubes were 
incubated at 20 °C or 37 °C for Group I and at 12 °C or 30 °C for Group II C. 
botulinum under anaerobic conditions. Growth and motility were followed over 
1–2 d at optimum and 1 week for suboptimal growth temperatures.
4.12  Electron microscopy (II, IV)
Bacterial cultures of the wild-type strain and the mutant strains were grown in 
TPGY broth to their early logarithmic growth phase at 20 °C or 37 °C for Group I 
and 12 °C or 30 °C for Group II strains. One ml of each culture was mixed with 1 
ml of 5% glutaraldehyde solution (Sigma-Aldrich) and incubated for 2 h at room 
temperature. The cells were washed with sterile water, and a drop of bacterial 
suspension was placed on carbon-coated grids (Electron Microscopy Sciences, 
Hatfield, PA, USA) and the preparation was stained in 1–3% phosphotungstic 
acid. The grids were examined with an FEI Tecnai 12 transmission electron 
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microscope (Philips Electron Optics, Eindhoven, The Netherlands) in the elec-
tron microscopy unit of the Institute of Biotechnology, University of Helsinki. 
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5  RESULTS
5.1  The 24 Group II C. botulinum strains vary in growth at 
extreme temperatures (I)
We observed variation among the Group II C. botulinum strains representing 
different toxin types and within the same toxin type with respect to growth 
characteristics. The mean maximum growth temperature was highest for type 
E strains, followed by types F and B with means of 39.0 ± 0.8, 37.8 ± 0.6, and 
36.6 ± 1.9 °C, respectively. When the mean minimum growth temperatures were 
considered, the lowest growth temperature was recorded for type B, followed 
by types E and F strains with means of 7.0 ± 0.9, 7.1 ± 0.6, and 7.8 ± 0.5 °C, 
respectively (Table 2 in I). The type E strains showed the widest variation in the 
minimum growth temperature, which ranged from 6.3 °C to 8.6 °C, whereas in 
the maximum growth temperatures, the widest variation was observed within the 
type B strains, with a difference of 3.8 °C between the highest and lowest values.
The mean maximum growth rates of all Group II strains examined were 
0.021 ± 0.012 at 10 °C, 0.357 ± 0.035 at 30 °C, 0.247 ± 0.107 at 37 °C, and 
0.060 ± 0.050 ODU/h at 40 °C (Table 3 in I). At 40 °C, growth was observed 
for only 11 of the type E strains. All type B strains included in the study, type E 
strains, K51, K101, and type F strains, 610B8-6, BL 86/32, and BL 86/34 grew 
significantly (P < 0.05) more slowly at 37 °C than at 30 °C. On the other hand, 
type E strains, CB11/1-1, K3, K119, S 16, and 31-2570 showed higher maximum 
growth rates at 37 °C than at 30 °C. The mean maximum growth temperature of 
the aforementioned five type E strains was higher than the mean of all strains 
together or the mean of all type E strains. Furthermore, the maximum growth 
temperatures of all strains and the difference between maximum growth rates 
at 37 °C and 30 °C were significantly (r = 0.85) correlated (Fig. 3 in I). Howev-
er, the association between the minimum growth temperature and maximum 
growth rates at 10 °C was less clear. Comparison of AFLP cluster analysis and 
growth characteristics revealed poor association among the Group II C. botu-
linum strains. Individual strains within the same AFLP cluster showed clear 
growth differences. As an indication of this, type E strain K101 was not able to 
grow at 40 °C, but it was one of the fastest growing strains at 10 °C. In contrast, 
strain 31-2570, belonging to the same AFLP cluster, showed the fastest growth 
at 40 °C, but grew poorly at 10 °C. 
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5.2  The cspB and cspC, but not cspA, mutants of Group I  
C. botulinum show reduced growth under stress conditions (II)
In all NaCl concentrations tested, the cspB mutant showed lower maximum 
growth rate and longer lag phase than did the wild-type strain. Under different 
pH conditions, the cspB mutant showed lower maximum growth rates, except at 
pH 8.0, and longer lag phase at all pH values tested than the wild-type strain. 
Except in 1.0% ethanol, the cspB mutant showed lower maximum growth rate 
and longer lag phase under all ethanol conditions than did the wild-type strain 
(Table 1 in II). 
The cspC mutant showed a longer lag phase than did the wild-type strain in 
1.0–4.0% added NaCl. Under the same conditions, its mean maximum growth 
rates were higher than those of the wild type. Growth at pH 5.5–8.0 showed 
lower maximum growth rate values for the cspC mutant than for the wild type. 
Under corresponding growth conditions, longer lag phases than for the wild-
type strain were observed, except at pH 5.5. Growth could be calculated in only 
1.0–3.0% ethanol for the cspC mutant. The mean maximum growth rate of the 
cspC mutant was lower than for the wild-type strain in 1.0% and 2.0%, but not 
in 3.0% ethanol. In addition, the lag phases of the cspC mutant were longer 
than for the wild-type strain under conditions in which growth was observed. 
The maximum growth rate of the cspA mutant was significantly higher (P 
< 0.05) in 3.0%, 3.5%, and 4.0% added NaCl than in the wild-type strain. 
However, this significantly faster growth was not reflected in the respective lag 
phases. The cspA mutant showed slightly longer lag phases than did the wild-
type strain in all NaCl concentrations tested. In acid stress, the cspA mutant 
at pH 5.0 showed no growth along with all strains included in the study. At 
all pH values tested, the cspA mutant showed similar maximum growth rates, 
but a shorter lag phase, than the wild-type strain. The cspA showed enhanced 
growth compared with the wild-type strain in 1.0–4.0% ethanol. Growth in 
5.0% ethanol was restrictive for all strains. 
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5.3  The two-component systems CBO2306/CBO2307 and 
CLO3403/CLO3404 are part of the cold-shock response 
mechanism in Group I C. botulinum ATCC 3502 and Group II  
C. botulinum Beluga strain, respectively (III, IV)
5.3.1 Different relative expression patterns of the CBO2306/CBO2307 and 
CLO3403/CLO3404 -engoding genes under optimum and cold-shock conditions 
(III, IV)
The relative mRNA levels of cbo2306 and cbo2307 were significantly lower (P 
< 0.01) at time points t3 (2 h) and t4 (5 h) than in the early logarithmic growth 
phase t0 (Fig. 1 in III). On the other hand, when the culture was subjected to 
cold shock (see section 4.5), the relative expressions of cbo2306 and cbo2307 
were significantly (P < 0.05) increased up to 1.6- to 4.4-fold at time points 30 
min, 2 h, and 5 h. When the relative mRNA levels of cbo2306 and cbo2307 in 
the cold-shock samples were calibrated to the optimum culture at the same time 
points, the difference was up to 24- and 36-fold, respectively. In the Group II 
Beluga strain, the relative mRNA levels of clo3403 and clo3404 were significantly 
(P < 0.05) lower at time points 5 h and 24 h than at time point t0 at optimum 
growth temperature (Fig. 1 in IV). After cold shock, clo3403 and clo3404 were 
induced up to 1.5- to 3.4-fold within 5 h compared with time point t0. How-
ever, 24 h after cold shock, clo3403 and clo3404 were significantly (P < 0.05) 
down-regulated. When the cold-shock induction levels of clo3403 and clo3404 
were calibrated to induction at optimal growth, an over 100-fold difference was 
observed at time point 5 h.
5.3.2  Growth characteristics of the cbo2306 and cbo2307 mutants (III)
Mutations in the cbo2306 and cbo2307 did not reflect noticeable differences 
in growth at 37 °C. In contrast, growth was markedly reduced for the mutant 
strains at 15 °C. At 15 °C, the OD of the wild-type strain was over 1.0 ODU, while 
the mutants were 0.6 ODUs or lower. In addition, the cbo2307a mutant did not 
show growth at all at 15 °C. Furthermore, the minimum growth temperatures 
of the mutants were significantly (P < 0.01) lower than in the wild-type strain, 
with the difference up to 3.8 °C. 
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5.3.3  Growth characteristics of the clo3403 and clo3404 mutants (IV) 
Mutational analysis of clo3403 and clo3404 showed no major effect on growth at 
30 °C. However, all mutant strains showed impaired growth at 12 °C compared 
with the wild-type strain. All mutants showed either extended lag phase or re-
duced ODU values. The maximum growth rates of the mutants were significantly 
(P < 0.01) lower than in the wild-type strain at 12 °C. The impaired growth of 
the CLO3403/CLO3404 TCS mutants was improved, and the maximum growth 
rates were restored by complementation of the mutations.
5.4  The cbo2802 DEAD-box RNA helicase is crucial for growth 
of C. botulinum ATCC 3502 at suboptimal temperature (V)
5.4.1 The cbo2802 DEAD-box RNA helicase of C. botulinum ATCC 3502 is induced 
at suboptimal temperature (V)
The relative expression analysis indicated a significant (P < 0.01) increase in 
cbo2802 transcription level 30 min, 2 h, and 5 h after cold shock (Fig. 1 in V). 
However, at the same time points the relative expression of cbo2802 was sig-
nificantly down-regulated in relation to early logarithmic growth phase under 
nonshock conditions. The relative level of expression was highest 30 min after 
the cold shock by 7.6-fold than before the cold shock. After 2 h, the expression 
level was similar (6.5-fold). The relative expression level of cbo2802 was reduced 
to 2-fold 5 h after the cold shock. 
5.4.2  Growth characteristics of the cbo2802 mutants (V) 
No major differences were seen between the growth of C. botulinum ATCC 
3502 wild type and the cbo2802s and cbo2802a mutant strains at 37 °C (Fig. 
3 in V). However, at 20 °C, impaired growth was observed for the cbo2802s 
and cbo2802a mutant strains (Fig. 3 in V). In addition, significant (P < 0.01) 
minimum growth temperature differences of 2.2 ± 0.4 °C for the cbo2802s 
mutant and 3.6 ± 0.5 °C for the cbo2802a mutant were noted, compared with 
the wild-type strain after 14 d of incubation. 
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5.5  Motility and flagella formation of the mutant strains (II, IV, V)
The cspA and cspB mutants showed reduced motility at 37 °C compared with 
the wild type. However, at 20 °C the cspA mutant was nonmotile, while the cspB 
mutant retained its motility. The cspC mutant was nonmotile regardless of the 
temperature. The mutation in clo3403a resulted in reduced motility at 12 °C 
compared with the wild-type strain. However, the clo3403s mutant showed a 
nonmotile phenotype at both 12 °C and 30 °C. The restricted motility of clo3403a 
and clo3403s were restored by complementation of the mutations. On the other 
hand, inactivation of clo3404 showed no major differences in motility. No dif-
ference was observed between the wild-type strain and the cbo2802 mutants 
at 37 °C. At 20 °C, cbo2802a showed reduced motility compared with the wild 
type and cbo2802s showed no motility.
Electron microscopy revealed that the cspA and cspC mutants with restricted 
motility did not form flagella, while we observed flagella formation in the mo-
tile cspB mutant. Similar observations were made for the clo3403 and clo3404 
mutants. The motile mutant strains and the wild type formed flagella, but no 
flagella were observed for the nonmotile mutant strain clo3403s. 
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6  DISCUSSION
6.1  Variation in the growth of Group II C. botulinum strains at 
extreme temperatures (I)
We found higher minimum growth temperatures than expected for the Group 
II C. botulinum strains studied. To determine the growth temperature bound-
aries, solid agar plates were used. This may have affected the bacterial growth, 
because the liquid medium supports bacterial growth better than does the solid 
agar (Hinderink et al., 2009). More interestingly, five type E strains (K3, K119, 
S16, CB11/1-1, and 31-2570) showed higher maximum growth rates at 37 °C 
than at 30 °C, indicating a mesophilic growth tendency for these strains. In 
contrast to the high prevalence of Group II C. botulinum in fish farms and sea 
sediments (Hielm et al., 1998a, 1998b; Hyytiä et al., 1998), the rare occurrence 
of botulism due to Group II strains may be explained by the mesophilic growth 
feature of these strains. They may require lengthy periods and considerable 
abuse in the storage temperature to grow and produce BoNT in foods. Never-
theless, the growth-permitting minimum temperature was below 9 °C for all 
Group II strains tested after 4 weeks. Considering that the average temperature 
of domestic refrigerators may be higher than 10 °C (Evans, 1998), Group II C. 
botulinum bacteria, even with their mesophilic growth characteristics, pose 
substantial safety hazards in foods, especially in REPFEDs. 
The AFLP analysis showed that the type B and F strains were clustered, 
whereas the type E strains formed a separate clade with two subsets of clusters. 
This pattern was consistent with that observed in previous studies (Keto-Tim-
onen et al., 2005; Hill et al., 2007, 2009). We could see no clear association 
between the clusters and temperature stress tolerance. Nevertheless, the type 
E strains apparently tolerate high temperatures better than do types B or F. 
One can expect faster growth at 37 °C than at 30 °C for the C. botulinum 
strains with high maximum growth temperature. However, this was not the 
case, even for the strain with the highest maximum growth temperature. On the 
other hand, strains within the same AFLP cluster with lower maximum growth 
temperature than the strain with the highest value showed better growth at 37 
°C than at 30 °C. Predicted phenotypic characteristics may not correlate with 
the physiology observed. For instance, Stringer and coworkers (2013) found a 
tellurite resistance gene in the type B and F strains studied that was not present 
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in the type E strains; therefore, they expected better tolerance for the type B and 
F strains to tellurite than in the type E strains. However, no such difference was 
observed. Furthermore, they reported no strong correlation between toxin type 
and minimum growth temperature or maximum NaCl concentration for growth. 
We observed differences in temperature tolerance among the 24 Group II C. 
botulinum strains. The ability of individual strains to tolerate various stresses at 
different levels is an important input in designing predictive models and food 
safety measures against C. botulinum. 
6.2  The role of csp genes in NaCl, pH, and ethanol stress 
response and motility (II)
We found that the cspB gene plays a central role in NaCl, pH, and ethanol stress 
responses. These data, together with coding of the major cold-shock protein, 
CspB, in Group I C. botulinum ATCC 3502 (Söderholm et al., 2011) suggests 
that cspB may play a universal role in the stress response of this bacterium. 
In L. monocytogenes, deletion of cspD, which is a homologue of the cspB of 
C. botulinum, resulted in a less NaCl-tolerant phenotype, and a hierarchy of 
functional importance was noted under cold and osmotic stress among csp 
genes (Schmid et al., 2009).
The impaired growth of the cspB mutant in NaCl stress was also observed 
for the cspC mutant, albeit to a lesser degree. Nevertheless, this indicates that 
cspC is also involved in osmotic stress. Such a degree of functional importance 
may be present in C. botulinum.
Under NaCl and low-pH stress, we observed a prolonged lag phase but similar 
maximum growth rates for the cspB and cspC mutants than for the wild-type 
strain. Apparently, once the growth is initiated, the maximum growth rate is 
mildly affected by mutations in the cspB or cspC genes. Growth phase-depen-
dent expression of CSPs has been reported in B. subtilis (Graumann et al., 1997; 
Graumann & Marahiel, 1999), thus cspB and cspC may play a more crucial role in 
adaptation than the exponential growth phase under low-pH and osmotic stress, 
and when the cells are adapted to a new environment, growth occurs normally.
Ethanol affected the growth of C. botulinum and the mutant strains dramat-
ically. At 5% (wt/wt) ethanol, growth of all strains was insufficient to calculate 
either the maximum growth rate or the lag phase, and growth was completely 
inhibited at 6% ethanol. This is in line with previously predicted growth-in-
hibiting ethanol concentrations (Daifas et al., 2000, 2003). The Gram-positive 
model organism B. subtilis recruits molecular chaperons into the cell membrane 
when exposed to ethanol (Seydlova et al., 2012). Clostridium botulinum may 
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also utilize a similar mechanism. Our results suggest that CspB together with 
CspC may be involved in the ethanol stress response. However, the exact role 
is unknown. 
The cspA mutant showed enhanced growth compared with the wild-type 
strain under NaCl, pH, and ethanol stress. Similarly, better growth for the cspA 
mutant than the parent ATCC 3502 at low and optimum temperatures was 
reported (Söderholm et al., 2011). The reason for such enhanced growth could 
be a growth repressor function of cspA.
A previous study indicated that mutation in the cspB and cspC, but not cspA, 
of C. botulinum ATCC 3502 resulted in a cold-sensitive phenotype (Söderholm 
et al., 2011). Cold-sensitive mutants acquire restricted motility (Mattila et al., 
2011; Palonen et al., 2011; Markkula et al., 2012a). However, in our study the 
cspB mutant did not result in restricted motility, and loss of motility in the cspC 
mutant appears to be temperature-independent. Interestingly, while the cspA 
mutant showed enhanced growth under stress conditions, it showed restricted 
motility at 20 °C. This could be explained by the observed lack of flagellation 
in the cspA and cspC mutants. Apparently, cspA and cspC, but not cspB, are 
involved in flagellation. 
6.3  Importance of the TCSs CBO2306/CBO2307 and 
CLO3403/3404 in cold tolerance of C. botulinum ATCC 3502 and 
Beluga E1, respectively, and involvement of CLO3403/3404 in 
motility (III, IV) 
The relative expressions of cbo2306 and cbo2307 in Group I and clo3403 and 
clo3404 in Group II C. botulinum were induced after cold shock, and the relative 
mRNA levels remained higher than at the time point before cold shock for 5 h. 
In contrast, such an induction pattern was not seen at optimum growth tem-
peratures for either of the strains. This suggests that increase in the expression 
of TCS genes is a response to temperature downshift. Such responses in TCSs 
have been documented in other foodborne pathogens, L. monocytogenes (Chan 
et al., 2008) and Y. pseudotuberculosis (Palonen et al., 2011). In addition, a 
cold-induced TCS in Group I C. botulinum ATCC 3502 was reported (Lindström 
et al., 2012).
The importance of both TCSs in cold response was demonstrated by the 
impaired growth of the insertional knockout mutants of cbo2306, cbo2307, 
clo3403, and clo3404 at low temperature. Furthermore, lower minimum growth 
temperatures for the cbo2306 and cbo2307 mutants, and restricted motility and 
flagellation for the clo3403 mutant were observed compared with the wild-type 
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strains. These observations indicate that functional CBO2306/2307 in Group I 
C. botulinum ATCC 3502 and CLO3403/3404 in Group II C. botulinum Beluga 
are required for efficient growth at low temperature. In addition, HK clo3403 
is required for motility and flagellation.
Even though all mutants were cold-sensitive, we observed differences in the 
phenotypes between the cbo2307s and cbo2307a or clo3403s and clo3403a 
mutants. The location of insertion may play a role in the level of variation in 
cold sensitivity. The insertion sites for the cbo2307s and cbo2307a mutants 
were both at the receiver domain, whereas clo3403s was targeted to the C-ter-
minal HAMP (Histidine kinases, Adenylyl cyclases, Methyl binding proteins, 
Phosphatases) domain and clo3403a was inserted into the N-terminal sensor 
domain. The polar effect caused by the strong erm promoter embedded in the 
insertions may also have been responsible (Heap et al., 2007). The sense-ori-
ented insertion could have decreased the expression of the downstream genes 
and also produced antisense RNA against the upstream genes, while the anti-
sense insertion may have enhanced the expression of the downstream genes. 
Nevertheless, the reduced cold tolerance of all mutants together in restoring 
the cold sensitivity and motility by complementing CLO3403/CLO3404 affirms 
the significance of these TCSs in the cold-stress response of C. botulinum ATCC 
3502 and Beluga E1.
6.4  The role of cbo2802 DEAD-box RNA helicase in growth of 
C. botulinum ATCC 3502 at suboptimal temperature (V)
The relative expression of cbo2802 was increased by 30 min after the cold shock 
and continued to be significantly up-regulated at 2 h and 5 h relative to before 
the cold shock. However, its expression was significantly decreased without 
cold shock at the same time points in relation to the early logarithmic phase. 
Therefore, increase in the relative mRNA level of cbo2802 is not the result of 
different growth phases, but the response to a temperature downshift. This 
cold-related induction is consistent with a microarray-based study in which 
expression of cbo2802 was significantly increased 1 h after cold shock (Dahlsten 
et al., 2014a). Low-temperature-related induction of DEAD-box RNA helicase 
genes has also been reported in other bacteria (Jones et al., 1996; Markkula et 
al., 2012a; Palonen et al., 2012).
The role of cbo2802 DEAD-box RNA helicase was further characterized by 
insertional inactivation of this gene in two insertional orientations. Both mu-
tant strains showed no growth differences at 37 °C, but impaired growth at 
20 °C compared with the wild-type strain. In addition, the minimum growth 
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temperatures of the cbo2802 mutants were significantly higher and motility 
was restricted at 20 °C in relation to the wild-type strain. Similarly, deletion 
of the DEAD-box RNA helicase genes of L. monocytogenes led to higher mini-
mum growth temperatures and restricted motility in mutants compared with the 
parent strain (Markkula et al., 2012a). Inactivation of DEAD-box RNA helicase 
has also resulted in cold-sensitive phenotypes in E. coli (Jones et al., 1996), B. 
subtilis (Hunger et al., 2006), and Y. pseudotuberculosis (Palonen et al., 2012). 
The highly conserved DEAD-box RNA helicases are involved in a wide range 
of aspects of RNA metabolism that is central to the response to cold stress (Panoff 
et al., 1998; Weber & Marahiel, 2003; Phadtare, 2004; Horn et al., 2007), but 
the exact function in cold stress is not well known. Awano and coworkers (2007) 
suggested that under cold stress, the primary role of DEAD-box RNA helicase is 
mRNA decay through helicase activity. Whether a similar role can be attribut-
ed to cbo2802 requires further research. Nevertheless, our results suggest that 
intact cbo2802 is required for efficient growth and motility at suboptimal, but 
not at optimum, growth temperatures in C. botulinum ATCC 3502.
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7  CONCLUSIONS
1. Group II C. botulinum strains varied significantly in their growth tempera-
ture range and maximum growth rate, and some strains showed a more 
mesophilic growth tendency than their generally accepted psychrotrophic 
growth features. Moreover, genetic typing indicated a low association be-
tween different C. botulinum strains and growth at extreme temperatures. 
The variation observed is of particular importance for developing predictive 
models of growth of Group II C. botulinum, and the ability of C. botulinum 
strains to grow in low temperatures is a remarkable threat to food safety.
2. The growth of the cspB mutant was impaired under all stress conditions 
tested. The cspC mutant also showed reduced growth in NaCl, pH, and 
ethanol stress. However, growth was not hampered by inactivation of cspA 
under the stress conditions tested. Apparently, cspB plays a global role in 
the stress response of Group I C. botulinum ATCC 3502 and inactivation 
of this gene has no effect on motility. The cspC mutant plays a complex 
role in stress response, and functional cspC is essential for motility and 
flagella formation at optimum and low temperatures. Inactivation of cspA 
enhances growth, due to a possible growth repressor role, and this gene is 
important for motility.
3. The relative mRNA levels of cbo2306 and cbo2307 in Group I C. botulinum 
ATCC 3502 and clo3403 and clo3404 in Group II C. botulinum Beluga 
were higher after cold shock in relation to their levels at optimum growth 
temperatures. This indicated an important role of TCSs encoded by these 
genes in adaptation to cold stress. This was further demonstrated by sig-
nificantly impaired growth of TCS mutants at low temperatures. Under 
cold stress, up-regulation of cbo2306, cbo2307, clo3403, and clo3404 is 
a rapid response to temperature downshift. In addition, the HK clo3403 
is required for motility and flagella formation. Clostridium botulinum has 
multiple TCSs that can be cold-inducible and required for efficient growth 
at low temperature.
4. The DEAD-box RNA helicase encoding cbo2802 of C. botulinum ATCC 3502 
was expressed rapidly after cold shock, which indicated that up-regulation 
of cbo2802 was a prompt response to cold. Mutants without functional 
cbo2802 showed delay in initiation of logarithmic growth phase, increased 
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minimum growth temperatures, and decreased maximum growth rates than 
did the parent ATCC 3502 strain, which establishes an important role of 
cbo2802 in growth at suboptimal temperature. Clostridium botulinum 
ATCC 3502 also requires intact cbo2802 for motility at low temperature. 
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